學術研究成果/Publication
|
基本資料/Profiles
|
姓名/Name: |
張兆祥
|
性別/Gender: |
男
|
英文姓名/ English Name: |
Chao-Hsiang Chang
|
英文縮寫/ Abbreviation: |
|
任職單位/ Affiliation: |
1.醫學院醫學系學士班泌尿學科(兼任副教授) / Department of Urology (Part-Time Associate Professor) 2.中國附醫泌尿部(顧問) / Department of Urology (Consultant)
|
Email: |
urology8395@mail.cmu.edu.tw
|
研究專長/Fields of Specialty
|
1﹒ |
泌尿腫瘤
|
2﹒ |
婦女尿失禁
|
3﹒ |
神經泌尿學
|
4﹒ |
微創手術
|
5﹒ |
達文西機器手臂輔助手術
|
|
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
|
SCI論文 |
鍾季容(Chi-Jung Chung)、(Hui-Ling Lee)、張兆祥(Chao-Hsiang Chang)、(Chih-Da Wu)、劉秋松(LIU, CHIU-SHONG)、(Mu-Chi Chung)、許惠悰(Hui-Tsung Hsu)*,Determination of potential sources of heavy metals in patients with urothelial carcinoma in central Taiwan - a biomonitoring case-control study,ENVIRONMENTAL GEOCHEMISTRY AND HEALTH,2023 Jul,45(7):5401-5414
|
SCI論文 |
曾浩翔(CHEN HAO XIANG)、尤律婷(YU LU-TING)、張菡(Han Chang)、黃煒軒(Wei-Hsuan Huang)、林維卿(Wei-Ching Lin)、張兆祥(Chao-Hsiang Chang)*,Combined Immunotherapy and Tyrosine Kinase Inhibitor Treatment for Metastatic Renal Cell Carcinoma With Unknown Primary Origin: A Report of Two Cases and Literature Review,IN VIVO,2023 Jul,37(4):1905-1913
|
SCI論文 |
曾浩翔(CHEN HAO XIANG)、蔡禮賢(Li-Hsien,Tsai)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、葉士芃(Shih-Peng Yeh)、連啟舜(Chi-Shun Lien)、楊啟瑞(Chi-Rei Yang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、謝博帆(Hsieh, Po-Fan)*、黃志平(Chi-Ping Huang)*,Enzalutamide prior to radium-223 is associated with better overall survival in metastatic castration-resistant prostate cancer patients compared to abiraterone - a retrospective study,Cancers,2023 Jul,15(13):3516-3516
|
SCI論文 |
(Mu-Chi Chung)、(Peir-Haur Hung)、蕭博任(Po-Jen Hsiao)、(Laing-You Wu)、張兆祥(Chao-Hsiang Chang)、(Kai-Yu Hsiao)、(Ming-Ju Wu)、(Jeng-Jer Shieh)、黃毓銓(Huang, Yu-Chuen)*、鍾季容(Chi-Jung Chung)*,Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan,JAMA Network Open,2023 Feb,6(2):e230453
|
SCI論文 |
謝博帆(Hsieh, Po-Fan)、李柏毅(LI PO-I)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、黃志平(Chi-Ping Huang)*,Learning Curve of Transperineal MRI/US Fusion Prostate Biopsy: 4-Year Experience,Life-Basel,2023 Feb,13():638
|
SCI論文 |
許凱文(Hsu, Kai-Wen)、賴玠羽(Joseph Chieh Yu Lai)、張正守(Jeng Shou Chang)、彭姵華(Pei Hua Peng)、黃瑾慧(Ching Hui Huang)、李德彥(Lee, Der-Yen)、蔡育成(Yu Cheng Tsai)、鍾季容(Chi-Jung Chung)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、陳紀琳(Ji Lin Chen)、馮思中(See Tong Pang)、郝子洋(Ziyang Hao)、崔曉龍(Xiao Long Cui)、何川(Chuan He)、吳國瑞(Kou Juey Wu)*,METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets,GENOME BIOLOGY,2022 Dec,23(1):249
|
SCI論文 |
邱亮維(CHIU LIANG-WEI)、蔡禮賢(Li-Hsien,Tsai)、謝博帆(Hsieh, Po-Fan)、陳汶吉(Wen-Chi Chen)、張兆祥(Chao-Hsiang Chang)*,Tuberculosis Epididymo-Orchitis Mimicking Malignancy Resulting from Intravesical Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: A Case Report of a Rare Complication,Diagnostics,2022 Oct,12():2663
|
SCI論文 |
(Mu-Chi Chung)、許惠悰(Hui-Tsung Hsu)、張兆祥(Chao-Hsiang Chang)、(Peir-Haur Hung)、蕭博任(Po-Jen Hsiao)、吳亮佑(Wu, Liang-You)、(Ming-Ju Wu)、(Jeng-Jer Shieh)、鍾季容(Chi-Jung Chung)*,Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis,Scientific Reports,2022 Jun,12():10147
|
SCI論文 |
(Hsin-Chih Yeh)、張兆祥(Chao-Hsiang Chang)、方仁愷(Fang Jen Kai)、(I-Hsuan Alan Chen)、(Jen-Tai Lin)、(Jian-Hua Hong)、(Chao-Yuan Huang)、(Shian-Shiang Wang)、(Chuan-Shu Chen)、(Chi-Wen Lo)、(Chih-Chin Yu)、(Jen-Shu Tseng)、(Te-Wei Lin)*,The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study,Frontiers in Oncology,2022 Jun,12():
|
SCI論文 |
謝博帆(Hsieh, Po-Fan)、張天佑(Tian-Yu Jhang)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、吳錫金(Hsi-Chin Wu)*,Saturation Target Biopsy can Overcome the Learning Curve of Magnetic Resonance Imaging/Ultrasound Fusion Biopsy of the Prostate,Journal of Mens Health,2022 May,18(6):127
|
SCI論文 |
謝博帆(Hsieh, Po-Fan)、張天佑(Tian-Yu Jhang)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、吳錫金(Hsi-Chin Wu)*,A comparative study of transperineal software-assisted magnetic resonance/ ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate,BMC Urology,2022 Apr,22():72
|
SCI論文 |
(Hsiang-Ying Lee1)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、(Chih-Chin Yu)、(Chi-Wen Lo)、(Shiu-Dong Chung)、(Wei-Che Wu)、(I-Hsuan Alan Chen)、(Jen-Tai Lin1)、(Yuan-Hong Jiang)、(Yu-Khun Lee)、(Thomas Y. Hsueh)、(Allen W. Chiu)、(Yung-Tai Chen)、(Chang-Min Lin)、(Yao-Chou Tsai)、(Wei-Chieh Chen)、(Bing-Juin Chiang)、(Hsu-Che Huang)、(Chung-Hsin Chen)、(Chao-Yuan Huang)、(Chia-Chang Wu)、(Wei Yu Lin)、(Jen-Shu Tseng)、(Hung-Lung Ke)、(Hsin-Chih Yeh)*,Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study,Frontiers in Oncology,2022 Apr,12(791620):
|
SCI論文 |
許惠悰(Hui-Tsung Hsu)、(Hui-Ling Lee)、(Hsu-Hui Cheng)、張兆祥(Chao-Hsiang Chang)、劉秋松(LIU, CHIU-SHONG)、蕭博任(Po-Jen Hsiao)、張菡(Han Chang)、連啟舜(Chi-Shun Lien)、(Mu-Chi Chung)、鍾季容(Chi-Jung Chung)*,Relationships of multiple metals exposure, global DNA methylation, and urothelial carcinoma in central Taiwan,ARCHIVES OF TOXICOLOGY,2022 Mar,0():0
|
SCI論文 |
(I-Hsuan Alan Chen)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、(Wen-Jeng Wu)、(Ching-Chia Li)、(Chung-Hsin Chen)、(Chao-Yuan Huang)、(Chi-Wen Lo)、(Chih-Chin Yu)、(Chung-You Tsai)、(Wei-Che Wu)、(Jen-Shu Tseng)、(Wun-Rong Lin)、(Yuan-Hong Jiang)、(Yu-Khun Lee)、(Yeong-Chin Jou)、(Ian-Seng Cheong)、(Thomas Y Hsueh)、(Allen W Chiu)、(Yung-Tai Chen)、(Jih-Sheng Chen)、(Bing-Juin Chiang)、(Yao-Chou Tsai)、(Wei Yu Lin)、(Chia-Chang Wu)、(Jen-Tai Lin)*、(Chia-Cheng Yu)*,Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan,Frontiers in Oncology,2022 Jan,11(766576):
|
SCI論文 |
謝博帆(Hsieh, Po-Fan)、李宗叡(LI TZUNG-RUEI)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、葉進仲(Chin-Chung Yeh)、黃文欽(Huang,Wen-Chin)、吳錫金(Hsi-Chin Wu)*,Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer,BMC Urology,2021 Nov,21():161
|
SCI論文 |
張天佑(Tian-Yu Jhang)、張兆祥(Chao-Hsiang Chang)、賴彬卿(Ping-Chin Lai)、林維卿(Wei-Ching Lin)*,Graft kidney hydronephrosis caused by transplant ureter inguinal hernia,MEDICINE,2021 May,100(21):e25965
|
Other論文 |
林維卿(Wei-Ching Lin)、張兆祥(Chao-Hsiang Chang)、張議徽(Yi-Huei Chang)、林建亨(Chien-Heng Lin)*,Three-dimensional Reconstruction of Renal Vascular Tumor Anatomy to facilitate accurate preoperative planning of partial nephrectomy,BioMedicine,2020 Dec,10(4):36-41
|
SCI論文 |
(Lian-Ching Yu)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、(Chao-Yuan Huang)、(Jian-Hua Hong)、(Ta-Yao Tai)、(Han-Yu Weng)、(Chi-Wen Lo)、(Chung-You Tsai)、(Yu-Khun Lee)、(Yao-Chou Tsai)、(Thomas Y. Hsueh)、(Yao-Chou Tsai)、(I-Hsuan Chen)、(Bing-Juin Chiang)、(Jen-Shu Tseng)、(Chia-Chang Wu)、(Wei-Yu Lin)、(Tsu-Ming Chien)、(Zai-Lin Sheu)、(Ching-Chia Li)、(Hung-Lung Ke)、(Hsiang-Ying Lee)、(Hsiang-Ying Lee)、(Wen-Jeng Wu)、(Hsin-Chih Yeh)*,Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan,Journal of Clinical Medicine,2020 Nov,9(12):3866
|
SCI論文 |
黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、王又平(Yu-Ping Wang)、王又德(Yu-De Wang)*,External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomy,BMC Urology,2020 Sep,20(1):146
|
SCI論文 |
賴俊佑(Chun-Yo Laih)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、張菡(Han Chang)、林維卿(Wei-Ching Lin)、賴俊鳴(Chun-Ming Lai)、張兆祥(Chao-Hsiang Chang)*,A retroperitoneal cavernous hemangioma arising from the gonadal vein,MEDICINE,2020 Sep,99(38):e22325
|
SCI論文 |
(Mu-Chi Chung)、(Tung-Min Yu)、(Ming-Ju Wu)、(Ya-Wen Chuang)、(Chih-Hsin Muo)、(Cheng-Hsu Chen)、張兆祥(Chao-Hsiang Chang)、(Jeng-Jer Shieh)、(Peir-Haur Hung)、(Jein-Wen Chen)、鍾季容(Chi-Jung Chung)*,Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan,BMC Nephrology,2020 Aug,21():348
|
SCI論文 |
鍾季容(Chi-Jung Chung)、許惠悰(Hui-Tsung Hsu)、張兆祥(Chao-Hsiang Chang)、(Li, S. W.)、劉秋松(Chiu-Shong Liu)、(Chung, M. C.)、吳國瑋(WU GUO-WEI)、(Jung, W. T.)、(Kuo, Y. J.)、(Lee, H. L.)*,Relationships among cigarette smoking, urinary biomarkers, and urothelial carcinoma risk: a case-control study,ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH,2020 Jul,():
|
SCI論文 |
(Peir-Haur Hung)、(Chien-Hung Lin)、(Kuan-Yu Hung)、(Chih-Hsin Muo)、(Mu-Chi Chung)、張兆祥(Chao-Hsiang Chang)、鍾季容(Chi-Jung Chung)*,Clinical burden of autosomal dominant polycystic kidney disease,Aging-US,2020 Apr,12():1-12
|
SCI論文 |
葉俊杰(Chun-Chieh Yeh)、(Arshad Khan)*、(Chih-Hsin Muo)、楊宏仁(Horng-Ren Yang)、李秉純(Ping-Chun Li)、張兆祥(Chao-Hsiang Chang)、(Ta-Liang Chen)、鄭隆賓(Long-Bin Jeng)、廖建彰(LIAO, CHIEN-CHANG)*,De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan,Experimental and Clinical Transplantation,2020 Apr,18(2):224-233
|
SCI論文 |
(Jian-Hua Hong)、(Chao-Yuan Huang)、張兆祥(Chao-Hsiang Chang)、(Chih-Hsin Muo)、(Fu-Shan Jaw)、(Yu-Chuan Lu)*、鍾季容(Chi-Jung Chung)*,Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model,Cancer Epidemiology,2020 Feb,64():101657
|
SCI論文 |
(Teng-Kai Yang)、(Chia-Chang Wu)、張兆祥(Chao-Hsiang Chang)、(Chih-Hsin Muo)、(Chao-Yuan Huang)、鍾季容(Chi-Jung Chung)*,Subsequent Risk of Acute Urinary Retention and Androgen Deprivation Therapy in Patients with Prostate Cancer: a population-based retrospective cohort study,MEDICINE,2020 Feb,99(7):e18842
|
SCI論文 |
(Yu-Chuan Lu)、(Chao-Yuan Huang)、(Huei-Ming Yeh)、(Jian-Hua Hong)、張兆祥(Chao-Hsiang Chang)、(Chih-Hsin Muo)、(Shiu-Dong Chung)、(Teng-Kai Yang)、(Fu-Shan Jaw)、鍾季容(Chi-Jung Chung)*,Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients,Scientific Reports,2019 Oct,9():14231
|
SCI論文 |
蔡禮賢(Li-Hsien,Tsai)、李瑋涓(Li, Wei-Juan)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh)、張兆祥(Chao-Hsiang Chang)*,Internal hernia from the interureteric space after robot-assisted radical cystectomy and urinary diversion Two case reports,MEDICINE,2019 Oct,98(41):
|
Other論文 |
蔡禮賢(Li-Hsien,Tsai)、張兆祥(Chao-Hsiang Chang)、陳思如(Szju-Ju Chen)、陳汶吉(Wen-Chi Chen)*,Randall’s Plaque, the Origin of Nephrolithiasis: Where Do We Stand Now?,Urological Science,2019 Sep,30(5):200-205
|
SCI論文 |
王又德(Yu-De Wang)、黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、王又平(Yu-Ping Wang)、謝博帆(Po-Fan Hsieh)*,The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting ipsilateral renal function after partial nephrectomy,BMC Urology,2019 Aug,19(1):72
|
SCI論文 |
謝博帆(Po-Fan Hsieh)、李瑋涓(Li, Wei-Juan)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Combining Prostate Health Index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population,WORLD JOURNAL OF UROLOGY,2019 Aug,.(.):.-.
|
SCI論文 |
鍾季容(Chi-Jung Chung)、(Hui-Ling Lee)、張兆祥(Chao-Hsiang Chang)、張菡(Han Chang)、劉秋松(Chiu-Shong Liu)、(Wei-Ting Jung)、(Huei-Ju Liu)、(Saou-Hsing Liou)、(Mu-Chi Chung)、(Yu-Mei Hsueh)*,Measurement of urinary arsenic profiles and DNA hypomethylation in a case–control study of urothelial carcinoma,ARCHIVES OF TOXICOLOGY,2019 Jul,93():2155-2164
|
SCI論文 |
連啟舜(Chi-Shun Lien)、鍾季容(Chi-Jung Chung)、林橙莉(Cheng-Li Lin)、張兆祥(Chao-Hsiang Chang)*,Increased Risk of Prostatitis in Male Patients with Depression,WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY,2019 Jun,June(14):1-8
|
Other論文 |
李聖偉(Sheng-Wei Li)、蕭博任(Po-Jen Hsiao)*、張兆祥(Chao-Hsiang Chang)、鄒頡龍(Chieh-Lung Chou),Lower urinary tract symptoms associated with Double-J stent,Urological Science,2019 May,30(3):92-98
|
Other論文 |
賴俊佑(Chun-Yo Laih)、張兆祥(Chao-Hsiang Chang)、陳汶吉(Wen-Chi Chen)*,Bladder Calculi in Taiwan,Urological Science,2019 Mar,(30):53-57
|
SCI論文 |
林詩怡(Shih-Yi Lin)、林橙莉(Cheng-Li Lin)、宋鴻樟(Fung-Chung J Sung)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、陳汶吉(Wen-Chi Chen)、王怡寬(I-Kuan Wang)、陳朝榮(Chao-Jung Chen)*、周安國(An-Kuo Chou)、高嘉鴻(Chia-Hung Kao)*,Risk of subsequent health disorders among living kidney donors,MEDICINE,2019 Feb,98(7):e14494
|
SCI論文 |
張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、林精湛(Ching-Chan Lin)*、張兆祥(Chang,Chao-Hsiang)、葉士芃(Su-Peng Yeh),Outcomes of Stage II to IV Upper Tract Urothelial Carcinoma and Adjuvant Chemotherapy for Localized Advanced cancer,Oncology Letters,2019 Jan,17(1):1341-1348
|
SCI論文 |
謝博帆(Po-Fan Hsieh)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、黃志平(Chi-Ping Huang)、陳汶吉(Wen-Chi Chen)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、連啟舜(Chi-Shun Lien)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4e10 ng/mL,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2018 Aug,34():461-466
|
Other論文 |
(Mu-Chi Chung)、(Tung-Min Yu)、(Ming-Ju Wu)、(Peir-Haur Hung)、張兆祥(Chang, Chao-Hsiang)、(Chih-Hsin Muo)、(Kuo-Hsiung Shu)、鍾季容(Chung, Chi-Jung)*,Increased Risk of Ischemic Stroke in Patients with Chronic Kidney Disease after Recurrent Dysnatremias: A Nationwide Population-Based Cohort Study,Neuropsychiatry,2018 Jun,8(2):587-594
|
Other論文 |
陳冠亨(Guang-Heng Chen)、王曦賢(Hsi-Hsien Wang)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、李聖偉(Sheng-Wei Li)、黃志平(Huang, Chi-Ping)、葉進仲(Yeh, Chin-Chung)、張兆祥(Chang, Chao-Hsiang)*,Evaluation of the relationship and postoperative glomerular filtration rate between the living donor and the recipients in kidney transplantation,Urological Science,2017 Dec,28(4):227-231
|
SCI論文 |
林詩怡(Lin, Shih-Yi)、林橙莉、張兆祥(Chang, Chao-Hsiang)、吳錫金(Wu, Hsi-Chin)、陳汶吉(Chen, Wen-Chi)、王怡寬(Wang, I-Kuan)、劉耀隆(Yao-Lung Liu)、宋鴻樟(Sung, Fung-Chang)、(Yen?Jung Chang)、高嘉鴻(Kao, Chia-Hung)*,Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study,Urolithiasis,2017 Oct,45(5):465-472
|
SCI論文 |
林詩怡(Lin, Shih-Yi)、林橙莉、張兆祥(Chang, Chao-Hsiang)、吳錫金(Wu, Hsi-Chin)、林志學(Lin, Chih-Hsueh)、高嘉鴻(Kao, Chia-Hung)*,Risk of age-related macular degeneration in patients with prostate cancer: a nationwide, population-based cohort study.,ANNALS OF ONCOLOGY,2017 Oct,28(10):2575-2580
|
SCI論文 |
張兆祥(Chang, Chao-Hsiang)、邱鴻傑(Hung-Chieh Chiu)、林維卿(Lin, Wei-Ching)、何子龍(Tzu-Lung Ho)、張菡(Chang, Han)、張議徽(Yi-Huei Chang)、黃志平(Huang, Chi-Ping)、吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、謝博帆(Po-Fan Hsieh)*,The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy,Biomed Research International,2017 Oct,2017():1-6
|
SCI論文 |
張議徽(Yi-Huei Chang)、蕭子玄(SIU JUSTIN JI-YUEN)、蕭博任(Po-Jen Hsiao)、張兆祥(Chang, Chao-Hsiang)、鄒頡龍(Chou, Chieh-Lung)*,Review of underactive bladder,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2017 Sep,():
|
Other論文 |
連啟舜(Chi-Shun Lien)、李聖偉(Sheng-Wei Li)、張兆祥(Chang, Chao-Hsiang)、鍾季容(Chung, Chi-Jung)、林橙莉、黃志平(Huang, Chi-Ping)*,Adult balanoposthitis patients have a higher risk of type 2 diabetes mellitus: A nationwide population-based cohort study,Urological Science,2017 Sep,():
|
Other論文 |
王又德(Yu-De Wang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、謝博帆(Po-Fan Hsieh)*,New-generation nephrometry systems: head-to-head comparison of tumor contact surface area and resected and ischemic volume,Urological Science,2017 Aug,28():84-88
|
SCI論文 |
(Mu-Chi Chung)、(Tung-Min Yu)、(Kuo-Hsiung Shu)、(Ming-Ju Wu)、張兆祥(Chang,Chao-Hsiang)、(Chih-Hsin Muo)、鍾季容(Chi-Jung Chung)*,Hyponatremia and increased risk of dementia: A population-based retrospective cohort study,PLoS One,2017 Jun,12(6):e0178977
|
SCI論文 |
林詩怡(Shih-Yi Lin)、林橙莉、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、王怡寬(I-Kuan Wang)、周哲毅(Che-Yi Chou)、梁基安(Ji-An Liang)*,Risk of acute myocardial infarction in upper tract urothelial carcinoma patients receiving radical nephroureterectomy: a population-based cohort study,Oncotarget,2017 Jun,():
|
SCI論文 |
鍾季容(Chi-Jung Chung)、張兆祥(Chang,Chao-Hsiang)、(Saou-Hsing Liou)、劉秋松(Chiu-Shong Liu)、(Huei-Ju Liu)、(Li-Ching Hsu)、(Jhih-Sheng Chen)、(Hui-Ling Lee)*,Relationships among DNA hypomethylation, Cd, and Pb exposure and risk of cigarette smoking-related urothelial carcinoma,TOXICOLOGY AND APPLIED PHARMACOLOGY,2017 Feb,316():107-113
|
SCI論文 |
(I-Ni Chiang)、(Chao-Yuan Huang)、(Yeong-Shiau Pu)、張兆祥(Chang,Chao-Hsiang)、(Chih-Hsin Muo)、鍾季容(Chi-Jung Chung)、王瑞筠(Ruey-Yun Wang)*、(Tai-Horng Young)*,Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study,BMJ Open,2017 Feb,7(2):e012950
|
SCI論文 |
黃煒軒(Wei-Hsuan Huaug)、張兆祥(Chang, Chao-Hsiang)、黃志平(Huang, Chi-Ping)、吳錫金(Wu, Hsi-Chin)、謝博帆(Po-Fan Hsieh)*,The percentage of resected and ischemic volume determined by a geometric model is a significant predictor of renal functional change after partial nephrectomy,International Braz J Urol,2017 Jan,43(1):80-86
|
Other論文 |
蕭子玄(SIU JUSTIN JI-YUEN)、楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)*,Salvage prostate cryoablation for recurrent localized prostate cancer after radiotherapy,Urological Science,2016 Dec,():
|
SCI論文 |
蕭子玄(SIU JUSTIN JI-YUEN)、陳慧毅(Huey-Yi Chen)、(Po-Chi Liao)、蔣仁槐(Chiang, Jen-Huai)、張兆祥(Chang,Chao-Hsiang)、陳永祥(Yung-Hsiang Chen)*、陳汶吉(Chen, Wen-Chi)*,The Cost-effectiveness of Treatment Modalities for Ureteral Stones: A National Comprehensive Study,INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING,2016 Oct,53():1-5
|
SCI論文 |
林詩怡(Shih-Yi Lin)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、林精湛(Ching-Chan Lin)、張凱博(Kai-Po Chang)、黃志平(Chi-Ping Huang)、徐武輝(Wu-Huei Hsu)、張志宗(Chiz-Tzung Chang)、陳朝榮(Chao-Jung Chen)*,Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma,Scientific Reports,2016 Sep,6():34446
|
SCI論文 |
(Peir-Haur Hung)、(Hung-Bin Tsai)、(Kuan-Yu Hung)、莫之欣、(Mu-Chi Chung)、張兆祥(Chang,Chao-Hsiang)、鍾季容(Chi-Jung Chung)*,Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy,Oncotarget,2016 Sep,7(38):61679-61689
|
SCI論文 |
謝博帆(Po-Fan Hsieh)、王又德(Yu-De Wang)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、陳冠亨(Guang-Heng Chen)、張兆祥(Chang,Chao-Hsiang)*,A Mathematical Method to Calculate Tumor Contact Surface Area: An Effective Parameter to Predict Renal Function after Partial Nephrectomy,JOURNAL OF UROLOGY,2016 Jul,196(1):33-39
|
SCI論文 |
蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、張議徽(Yi-Huei Chang)、張兆祥(Chang,Chao-Hsiang)*、張菡(Han Chang)、白禮源(Li-Yuan Bai),An unresectable retroperitoneal malignant fibrous histiocytoma: a case report,Oncology Letters,2016 Apr,11(4):2403-2407
|
SCI論文 |
張兆祥(Chang,Chao-Hsiang)、劉秋松(Chiu-Shong Liu)、(Huei-Ju Liu)、黃志平(Chi-Ping Huang)、(Chao-Yuan Huang)、許惠悰(Hui-Tsung Hsu)、(Saou-Hsing Liou)、鍾季容(Chi-Jung Chung)*,Association between levels of urinary heavy metals and increased risk of urothelial carcinoma,INTERNATIONAL JOURNAL OF UROLOGY,2016 Mar,23(3):233-239
|
SCI論文 |
蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)*,Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients,RENAL FAILURE,2016 Mar,38(5):663-670
|
SCI論文 |
(Tung-Min Yu)、林則成(Lin, Che-Chen)、(Kuo-Hsiung Shu)、(Ya-Wen Chuang)、(Shih-Ting Huang)、(Cheng-Hsu Chen)、(Ming-Ju Wu)、(Mu-Chi Chung)、張兆祥(Chang,Chao-Hsiang)、李繼源(Chi-Yuan Li)*、鍾季容(Chi-Jung Chung)*,Increased risk of hepatic complications in kidney transplantation with chronic virus hepatitis infection: A nationwide population-based cohort study,Scientific Reports,2016 Feb,6():21312-21319
|
SCI論文 |
謝博帆(Po-Fan Hsieh)、邱鴻傑(Hung-Chieh Chiu)、陳冠潔(Kuan-Chieh Chen)、張兆祥(Chang,Chao-Hsiang)、鄒頡龍(Chieh-Lung Chou)*,Botulinum toxin A for the Treatment of Overactive Bladder,Toxins,2016 Feb,8(3):.-.
|
SCI論文 |
(Shiu-Dong Chung)、張兆祥(Chang,Chao-Hsiang)、(Peir-Haur Hung)、鍾季容(Chi-Jung Chung)、莫之欣、(Chao-Yuan Huang)*,Correlation Between Bladder Pain Syndrome/Interstitial Cystitis and Pelvic Inflammatory Disease,MEDICINE,2015 Nov,94(46):e1878-e1890
|
SCI論文 |
邱鴻傑(Hung-Chieh Chiu)、張兆祥(Chang,Chao-Hsiang)、謝博帆(Po-Fan Hsieh)*,Isolated Urethral Rupture Related To Sexual Intercourse in Male and Literature review,Urology Journal,2015 Nov,12(06):2462-2464
|
Other論文 |
張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、張兆祥(Chang,Chao-Hsiang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)*、鍾季容(Chi-Jung Chung)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Chen, Kuo-Liang),Economic fluctuation affects vasectomy utilization: A single-institution study,Urological Science,2015 Sep,26(3):214-217
|
SCI論文 |
(Teng-Kai Yang)、鍾季容(Chi-Jung Chung)、(Shiu-Dong Chung)、莫之欣、張兆祥(Chang,Chao-Hsiang)、(Chao-Yuan Huang)*,Risk of endometrial cancer in women with pelvic inflammatory disease: A nationwide population-based retrospective cohort study,MEDICINE,2015 Aug,94(34):e1278
|
Other論文 |
張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)*,The value of cystography in the prediction of early urinary continence after radical prostatectomy,Urological Science,2015 Aug,():
|
SCI論文 |
連啟舜(Chi-Shun Lien)、黃志平(Chi-Ping Huang)、鍾季容(Chi-Jung Chung)、林橙莉、張兆祥(Chang,Chao-Hsiang)*,Increased risk of anxiety among patients with urolithiasis: A nationwide population-based cohort study,INTERNATIONAL JOURNAL OF UROLOGY,2015 Jul,0():
|
SCI論文 |
鍾季容(Chi-Jung Chung)、張兆祥(Chang,Chao-Hsiang)、褚志斌(Chih-Pin Chuu)、楊啟瑞(Che-Rei Yang)、張議徽(Yi-Huei Chang)、黃志平(Chi-Ping Huang)、陳汶吉(Chen, Wen-Chi)、(Mu-Chi Chung)、張菡(Han Chang)*,Reduced 5-Methylcytosine Level as a Potential Progression Predictor in Patients with T1 or Non-Invasive Urothelial Carcinoma,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2015 Jan,16():677-690
|
SCI論文 |
(Mu-Chi Chung)、(Ming-Ju Wu)、張兆祥(Chang,Chao-Hsiang)、(Chih-Hsin Muo)、(Tung-Min Yu)、(Hao-Chung Ho)、(Kuo-Hsiung Shu)、鍾季容(Chi-Jung Chung)*,Increased Risk of Post-Transplant Malignancy and Mortality in Transplant Tourists: a nationwide population-based cohort study in Taiwan,MEDICINE,2014 Dec,93(29):e344
|
SCI論文 |
(Hung, P. H.)、(Tsai, H. B.)、(Hung, K. Y.)、莫之欣、(Chung, M. C.)、張兆祥(Chang,Chao-Hsiang)、鍾季容(Chi-Jung Chung)*,Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study,MEDICINE,2014 Aug,93(8):e52-e58
|
SCI論文 |
(Shun-Fa Hung)、(Chao-Yuan Huang)、林橙莉、(Shiu-Dong Chung)、鍾季容(Chi-Jung Chung)、高嘉鴻(Chia-Hung Kao)*、張兆祥(Chang,Chao-Hsiang)*,Increased Risk of Acute Coronary Syndrome among Patients with Urinary Stone Disease: A Nationwide Population-Based Cohort Study.,PLoS One,2014 Jul,9(7):102349
|
SCI論文 |
陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、陳至正(Chi-Cheng Chen)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、陳國樑(Chen, Kuo-Liang)、鄒頡龍(Chieh-Lung Chou)、陳汶吉(Chen, Wen-Chi)、張兆祥(Chang,Chao-Hsiang)*,Spontaneous ureteral rupture and review of the literature,AMERICAN JOURNAL OF EMERGENCY MEDICINE,2014 Jul,32(7):772-774
|
SSCI論文 |
鄒頡龍(Chieh-Lung Chou)、謝博帆(Po-Fan Hsieh)、陳國樑(Chen, Kuo-Liang)、張兆祥(Chang,Chao-Hsiang)、杭良文(Liang-Wen Hang)、梁信杰(Shinn-Jye Liang)*,Continuous positive airway pressure (CPAP) therapy improves stage 1 and stage 2 sleep nocturia in patients with obstructive sleep apnea,JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,2014 ,():
|
SCI論文 |
謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、連啟舜(Chi-Shun Lien)、吳錫金(Wu,Hsi-Chin)、蕭博任(Po-Jen Hsiao)、鄒頡龍(Chieh-Lung Chou)*,Remote monitoring of videourodynamics using smart phone and free instant messaging software,NEUROUROLOGY AND URODYNAMICS,2013 Jul,():
|
SCI論文 |
(Teng-Fu Hsieh)、(Chi-Cheng Chen)、張兆祥(Chang,Chao-Hsiang)、游艾琳(Ai-lin Yu)、馬文隆(Wen-Lung Ma)、石志榮(Chih-Rong, Shyr)*,The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test,EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY,2013 May,65():703-708
|
SCI論文 |
(Chi-Cheng Chen)、(Teng-Fu Hsieh)、張兆祥(Chang,Chao-Hsiang)、馬文隆(Wen-Lung Ma)、(Xiao-Fan Hung)、蔡宜儒(Yi-Ru Tsai)、(Meng-Hsueh Amanda Lin)、(Caixia Zhang)、張傳祥(Chawnshang Chang)*、石志榮(Chih-Rong, Shyr)*,Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2,ONCOLOGY REPORTS,2013 May,(30):975-985
|
Other論文 |
謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)、陳至正(Chi-Cheng Chen)、陳國樑(Chen, Kuo-Liang)、張士三(Chang, Shi-San)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、鄒頡龍(Chieh-Lung Chou)、吳錫金(Wu,Hsi-Chin)*,C index is associated with both short-term and long-term renal functional outcome after partial nephrectomy,Urological Science,2013 May,24(2):46-50
|
Other論文 |
連啟舜(Chi-Shun Lien)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Chen, Wen-Chi)*,Genital chlamydial infection in Taiwan,Urological Science,2013 Apr,24(1):7-9
|
SCI論文 |
石志榮(Chih-Rong, Shyr)*、Chen, C. C.、(Hsieh, T. F)、張兆祥(Chang,Chao-Hsiang)、馬文隆(Wen-Lung Ma)、(Yeh, S.)、(Messing, E.)、(Li, T. H.)、(Li, F. Y.)、張傳祥(Chawnshang Chang),The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells,ENDOCRINE,2013 Jan,43(1):191-199
|
SCI論文 |
林維卿(Wei-Ching Lin)、林建亨(Chien-Heng Lin)、陳中和(Jeon-Hor Chen)、陳永芳(Yung-Fang Chen)、張兆祥(Chang,Chao-Hsiang)、吳汐淇(Shih-Chi Wu)、許正男(Cheng-Nan Hsu)、林建宏、何永仁(Yung-Jen Ho)*,Computed tomographic imaging in determining the need of embolization for high-grade blunt renal injury,Journal of Trauma and Acute Care Surgery,2013 Jan,74(1):230-235
|
Other論文 |
張文馨(Wen-Shin Chang)、蔡佳紋(Chia-Wen Tsai)、鄭光皓(Kuang-Hao Cheng)、連啟舜(Chi-Shun Lien)、黃志平(Chi-Ping Huang)、廖文玲(Wen-Ling Liao)、李孟軒(Meng-Hsuan Lee)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、林正介(Cheng-Chieh Lin)、包大靝(Da-Tian Bau)*,The Role of APEX1/Ref-1 (apurinic/apyrimidic endonuclease DNA-repair gene) in Renal Cell Carcinoma,Adaptive Medicine,2012 Dec,4(4):216-223
|
SCI論文 |
鍾季容(Chi-Jung Chung)、(Chao-Yuan Huang)、(Hung-Bin Tsai)、(Chih-Hsin Muo)、(Mu-Chi Chung)、張兆祥(Chang,Chao-Hsiang)、黃秋錦(Chiu-Ching Huang)*,Sex Differences in the Development of Malignancies among End-stage Renal Disease Patients: A Nationwide Population-based Follow-up Study in Taiwan,PLoS One,2012 Sep,7(9):e44675-e44675
|
SCI論文 |
張文馨(Wen-Shin Chang)、(Hung-Lung Ke)、蔡佳紋(Chia-Wen Tsai)、連啟舜(Chi-Shun Lien)、廖文玲(Wen-Ling Liao)、(Hui-Hui Lin)、李孟軒(Meng-Hsuan Lee)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、陳至正(Chi-Cheng Chen)、李鳳琴(Hong-Zin Lee)、包大靝(Da-Tian Bau)*,The role of XRCC6 functional polymorphism T-991C in renal cell carcinoma,ANTICANCER RESEARCH,2012 Sep,32(9):3855-3860
|
SCI論文 |
謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、黃志平(Chi-Ping Huang)、陳至正(Chen, Chi-Cheng)、陳國樑(Chen, Kuo-Liang)、張士三(Chang, Shi-San)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、鄒頡龍(Chieh-Lung Chou)、吳錫金(Wu,Hsi-Chin)*,The impact of gender and size on the pathology of small renal mass,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2012 Jul,28(7):369-372
|
Other論文 |
陳國樑(Chen, Kuo-Liang)*、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang),Tissue-engineered constructs for urethral regeneration,Urological Science,2012 Jun,23(2):42-44
|
SCI論文 |
施秉庚(Pin-Keng Shih)、吳曉舒(Hsiao-Su Wu)、張家寧(Sophia Chia-Ning Chang)、(Jack Chung-Kai Yu)、張兆祥(Chang,Chao-Hsiang)*,Restoration of Glans Penis Defect by a Bipedicled Foreskin Flap,ANNALS OF PLASTIC SURGERY,2012 Apr,():
|
Other論文 |
(CH Liu)、魏長菁(Chang-Ching Wei)、李佳盈(Chia-Ying Lee)、張兆祥(Chang,Chao-Hsiang)、林清淵(Ching-Yuang Lin)*,Difference in Clinical Features between Pheochromocytoma and Paraganglioma,臺灣腎臟醫學會雜誌,2011 Dec,25(4):161-166
|
Other論文 |
(Chia-Hung Liu)、李佳盈(Chia-Ying Lee)、魏長菁(Chang-Ching Wei)、張兆祥(Chang,Chao-Hsiang)、林清淵(Ching-Yuang Lin)*,Pediatric Suprarenal Paraganglioma Presented as Blurred Vision-A Case Report,臺灣腎臟醫學會雜誌,2011 Dec,25(4):196-200
|
Other論文 |
張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、(Hung-Lung Ke)、(Hui-Hui Lin)、沈戊忠(Wu-Chung Shen)、孫盛生(Shung-Shung Sun)、蔡佳紋(Chia-Wen Tsai)、(Ru-Yin Tsai)、包大靝(Da-Tian Bau)*,The Genetic Role of Cyclooxygenase 2 in Ureter Cancer in Taiwan,Adaptive Medicine,2011 Oct,3(2):99-105
|
SCI論文 |
鄒頡龍(Chieh-Lung Chou)、楊佩瑜(Pei-Yu Yang)、薛文惠(Wen-Hui Hsueh)、張兆祥(Chang,Chao-Hsiang)、孟乃欣(Nai-Hsin Meng)*,Urinating in the Standing Position: a Feasible Alternative for Elderly Women with Knee Osteoarthritis,JOURNAL OF UROLOGY,2011 Sep,186(3):.949-.953
|
SCI論文 |
包大靝(Da-Tian Bau)、張兆祥(Chang,Chao-Hsiang)、(Ru-Yin Tsai)、王惠暢(Hwei-Chung Wang)、(Rou-Fen Wang)、蔡佳紋(Chia-Wen Tsai)、姚俊旭(Chun-Hsu Yao)、陳悦生(Yueh-Sheng Chen)、徐松錕(Song-Kun Shyue)、黃志揚(Chih-Yang Huang)*,Significant Association of Caveolin-1 Genotypes with Bladder Cancer Susceptibility in Taiwan,CHINESE JOURNAL OF PHYSIOLOGY,2011 Jul,54(3):153-160
|
SCI論文 |
張兆祥(Chang,Chao-Hsiang)、彭賢祐(Hsien-Yu Peng)、吳錫金(Wu,Hsi-Chin)、(Cheng-Yuan Lai)、(Ming-Chun Hsieh)、林則彬(Tzer-Bin Lin)*,Cyclophosphamide induces NR2B phosphorylation-dependent facilitation on spinal reflex potentiation.,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2011 Mar,300.(3.):F692.-9.
|
Other論文 |
謝博帆(Po-Fan Hsieh)*、陳冠亨(Guang-Heng Chen)、(Sung-Ting Chen)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、鄒頡龍(Chieh-Lung Chou),Polypoid Cystitis Presenting as a Protruding Urethral Mass,台灣泌尿科醫學會雜誌,2011 Mar,22(1):46-48
|
SCI論文 |
吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、彭賢祐(Hsien-Yu Peng)、(Gin-Den Chen)、(Cheng-Yuan Lai)、(Ming-Chun Hsieh)、林則彬(Tzer-Bin Lin)*,EphrinB2 induces pelvic-urethra reflex potentiation via Src kinase-dependent tyrosine phosphorylation of NR2B.,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2011 Feb,300(2):F403-F411
|
SCI論文 |
吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、鄒永恩(Yung-An Tsou)、蔡佳紋(Chia-Wen Tsai)、林正介(Cheng-Chieh Lin)*、包大靝(Da-Tian Bau)*,Significant Association of Caveolin-1 (Cav-1) Genotypes with Prostate Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2011 Feb,31(2):745-749
|
SCI論文 |
彭賢祐(Hsien-Yu Peng)、張兆祥(Chang,Chao-Hsiang)、(Shin-Jei Tsai)、(Cheng-Yuan Lai)、(Kwong-Chung Tung)、吳錫金(Wu,Hsi-Chin)*、林則彬(Tzer-Bin Lin)*,Protein kinase A-dependent spinal α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate receptor trafficking mediates the capsaicin-induced colon-urethra cross-organ reflex sensitization.,ANESTHESIOLOGY,2011 Jan,114(1):70-83
|
SCI論文 |
吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、(HUNG-LUNG KE)、張文馨(WEN-SHIN CHANG)、(HUI-NI CHENG)、(HUI-HUI LIN)、(CHI-YU WU)、蔡佳紋(CHIA-WEN TSAI)、(RU-YIN TSAI)、羅偉忠(Lo Woei Chung)、包大靝(Da-Tian Bau)*,Associations of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer in Taiwan,ANTICANCER RESEARCH,2011 Jan,31(1):221-226
|
SCI論文 |
包大靝(Da-Tian Bau)*、張兆祥(Chang,Chao-Hsiang)、蔡銘修(Ming-Hsui Tsai)、邱昌芳(Chang-Fang Chiu)、鄒永恩(Yung-An Tsou)、王柔分(Rou-Fen Wang)、蔡佳紋(Chia-Wen Tsai)、蔡如愔(Ru-Yin Tsai)*,Association Between DNA Repair Gene ATM Polymorphisms and Oral Cancer Susceptibility,LARYNGOSCOPE,2010 Dec,120(12):2417-2422
|
SCI論文 |
陳至正(Chen, Chi-Cheng)、張兆祥(Chang,Chao-Hsiang)、劉耀隆(Yao-Lung Liu)、劉炯勳(Jiung-Hsiun Liu)*、黃秋錦(Chiu-Ching Huang),A Tiny Stone Induced Ureteral Rupture,ANNALS ACADEMY OF MEDICINE SINGAPORE,2010 Dec,39(12):948-949
|
SCI論文 |
(CHENG-HSING HSIEH)、(HENG-SHUEN CHEN)、李文源(Wen-Yuan Lee)、陳國樑(Chen, Kuo-Liang)、張兆祥(Chang,Chao-Hsiang)、許耕榕(Geng-Long Hsu)*,Salvage Penile Curvature Correction Surgery,JOURNAL OF ANDROLOGY,2010 Sep,31(5):450-456
|
SCI論文 |
鄒頡龍(Chieh-Lung Chou)、張兆祥(Chang,Chao-Hsiang)、陳至正(Chen, Chi-Cheng)、吳錫金(Wu,Hsi-Chin)、吳博倫(Po-Lun Wu)、陳國樑(Chen, Kuo-Liang)*,Women Urinate in the Standing Position Do Not Increase Post-Void Residual Urine Volumes,NEUROUROLOGY AND URODYNAMICS,2010 Sep,29(7):1299-1300
|
SCI論文 |
吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、蔡如愔(RU-YIN TSAI)、林志學(Chih-Hsueh Lin)、王柔分(ROU-FEN WANG)、蔡佳紋(CHIA-WEN TSAI)、陳坤堡(Kuen-Bao Chen)、姚俊旭(Chun-Hsu Yao)、邱昌芳(Chang-Fang Chiu)、包大靝(Da-Tian Bau)*、林正介(Cheng-Chieh Lin)*,Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan,ANTICANCER RESEARCH,2010 Sep,30(9):3573-3578
|
Other論文 |
楊美都(Mei-Due Yang)、蔡如愔(Ru-Yin Tsai)、劉秋松(Chiu-Shong Liu)、張兆祥(Chang,Chao-Hsiang)、王惠暢(Hwei-Chung Wang)、鄒永恩(Yung-An Tsou)、王仲興(Chung-Hsing Wang)、林正介(Cheng-Chieh Lin)、徐松錕(Song-Kun Shyue)、包大靝(Da-Tian Bau)*,Association of Caveolin-1 polymorphisms with colorectal cancer susceptibility in Taiwan,World Journal of Gastrointestinal Oncology,2010 Aug,2(8):326-331
|
SCI論文 |
孟乃欣(Nai-Hsin Meng)、羅瑞寬(Sui-Foon Lo)、周立偉(Li-Wei Chou)、楊佩瑜(Pei-Yu Yang)、張兆祥(Chang,Chao-Hsiang)、鄒頡龍(Chieh-Lung Chou)*,Incomplete Bladder Emptying in Patients with Stroke: Is Detrusor-External Sphincter Dyssynergia A Potential Cause?,ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION,2010 Jul,91(7):1105-1109
|
SCI論文 |
許耕榕(Geng-Long Hsu)*、(HENG-SHUEN CHEN)、(CHENG-HSING HSIEH)、李文源(Wen-Yuan Lee)、陳國樑(Chen, Kuo-Liang)、張兆祥(Chang,Chao-Hsiang),Clinical Experience of a Refined Penile Venous Stripping Surgery Procedure for Patients with Erectile Dysfunction: Is It a Viable Option?,JOURNAL OF ANDROLOGY,2010 Jun,3(31):271-280
|
SCI論文 |
吳昱(Yu-Chin Wu)、張兆祥(Chang,Chao-Hsiang)、謝德鈞(Te-Chun Hsieh)、高嘉鴻(Chia-Hung Kao)、顏國揚(Kuo-Yang Yen)、王之秀(Chih-Hsiu Wang)、林裕益(Yu-Yi Lin)、孫盛生(Shung-Shung Sun)*,Unusual Case with Multi-organ Gallium-avid Metastases of Renal Cell Carcinoma,AMERICAN JOURNAL OF THE MEDICAL SCIENCES,2010 Mar,339(3):275-275
|
SCI論文 |
王惠暢(Hwei-Chung Wang)、劉秋松(Chiu-Shong Liu)、王仲興(Chung-Hsing Wang)、蔡如愔(Ru-Yin Tsai)、蔡佳紋(Chia-Wen Tsai)、王柔分(Rou-Fen Wang)、張兆祥(Chang,Chao-Hsiang)、陳悦生(Yueh-Sheng Chen)、邱昌芳(Chang-Fang Chiu)*、包大靝(Da-Tian Bau)*、黃志揚(Chih-Yang Huang)*,Significant Association of XPD Asp312Asn Polymorphism with Breast Cancer in Taiwanese Patients,CHINESE JOURNAL OF PHYSIOLOGY,2010 Mar,53(2):130-135
|
Other論文 |
林易霆(Lin, Yi-Ting)、張兆祥(Chang,Chao-Hsiang)*、陳汶吉(Chen, Wen-Chi),Asymptomatic Congenital Splenorenal Shunt in a Noncirrhotic Patient With a Left Adrenal Aldosterone-producing Adenoma,kaohsiung Journal of Medical Sciences,2009 Dec,25(12):669-674
|
SCI論文 |
張兆祥(Chang,Chao-Hsiang)、邱昌芳(Chang-Fang Chiu)、王惠暢(Hwei-Chung Wang)、蔡如愔(Ru-Yin Tsai)、蔡佳紋(Chia-Wen Tsai)、王柔分(Rou-Fen WAng)、王仲興(Chung-Hsing Wang)、鄒永恩(Yung-An Tsou)、包大靝(Da-Tian Bau)*,Significant Association of ERCC6 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2009 Dec,29(12):5121-5124
|
SCI論文 |
張兆祥(Chang,Chao-Hsiang)、王柔分(ROU-FEN WANG)、蔡如愔(RU-YIN TSAI)、吳錫金(Wu,Hsi-Chin)、王仲興(Chung-Hsing Wang)、蔡佳紋(CHIA-WEN TSAI)、張佳霖(CHIA-LIN CHANG)、鄒永恩(Yung-An Tsou)、劉秋松(Chiu-Shong Liu)、包大靝(Da-Tian Bau)*,Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.,ANTICANCER RESEARCH,2009 Oct,29(10):3903-3907
|
SCI論文 |
王惠暢(Hwei-Chung Wang)、邱昌芳(Chang-Fang Chiu)、蔡如愔(Ru-Yin Tsai)、郭永順(YUNG-SHUN KUO)、陳華襄(HUA-SHIANG CHEN)、王柔分(ROU-FEN WANG)、蔡佳紋(CHIA-WEN TSAI)、張兆祥(Chang,Chao-Hsiang)*、林正介(Cheng-Chieh Lin)*、包大靝(Da-Tian Bau)*,Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan.,ANTICANCER RESEARCH,2009 Oct,29(10):3897-3902
|
SCI論文 |
孫盛生(Shung-Shung Sun)、張兆祥(Chang,Chao-Hsiang)、丁慧枝(Hueisch-Jy Ding)、高嘉鴻(Chia-Hung Kao)、吳錫金(Wu,Hsi-Chin)、謝德鈞(Te-Chun Hsieh)*,Preliminary Study of Detecting Urothelial Malignancy with FDG PET in Taiwanese ESRD Patients,ANTICANCER RESEARCH,2009 Aug,29(8):3459-3464
|
Other論文 |
陳至正(Chen, Chi-Cheng)、張兆祥(Chang,Chao-Hsiang)*、吳錫金(Wu,Hsi-Chin)、葉進仲(Yeh, Chin-Chung)、鄒頡龍(Chieh-Lung Chou)、謝登富(Deng-Fu Hsieh)、陳汶吉(Chen, Wen-Chi)*,Detecting Upper Urinary Tract Malignancy in Patients with Staghorn stone: Results of a Routine Biopsy,Current urology reports,2009 Aug,3(2):61-67
|
SCI論文 |
楊美都(Mei-Due Yang)、徐媛曼(Yuan-Man Hsu)、郭永順(Yung-Shun Kuo)、陳華襄(Hua-Shiang Chen)、張嘉琳(Chia-Ling Chang)、吳正男(Cheng-Nan Wu)、張兆祥(Chang,Chao-Hsiang)、廖裕民(Yu-Min Liao)、王惠暢(Hwei-Chung Wang)*、(Ming-Fu Wang)、包大靝(Da-Tian Bau)*,Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in central Taiwan,ANTICANCER RESEARCH,2009 Jun,29(1):2239-2242
|
SCI論文 |
張兆祥(Chang,Chao-Hsiang)、邱昌芳(Chang-Fang Chiu)、(Shiu-Yun Liang)、吳錫金(Wu,Hsi-Chin)、張嘉琳(Chia-Lin Chang)、蔡佳紋(Chia-Wen Tsai)、王惠暢(Hwei-Chung Wang)、李鳳琴(Hong-Zin Lee)*、包大靝(Da-Tian Bau)*,Significant Association of Ku80 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2009 May,29(1):1275-1280
|
SCI論文 |
張兆祥(Chang,Chao-Hsiang)、張嘉琳(CHIA-LIN CHANG)、蔡佳紋(CHIA-WEN TSAI)、吳錫金(Wu,Hsi-Chin)、邱昌芳(Chang-Fang Chiu)、王柔分(ROU-FEN WANG)、劉秋松(Chiu-Shong Liu)、林正介(Cheng-Chieh Lin)、包大靝(Da-Tian Bau)*,Significant Association of an XRCC4 Single Nucleotide Polymorphism with Bladder Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2009 May,29(5):1777-1782
|
SCI論文 |
林維卿(Wei-Ching Lin)、陳永芳(Yung-Fang Chen)、林建亨(Chien-Heng Lin)、何永仁(Yung-Jen Ho)、曾元宏(Yuan-Hong Tzeng)、蔣咸嘉(Hsein-Jar Chiang)、張兆祥(Chang,Chao-Hsiang)、鄭宜昌(Yi-Chang Cheng)、沈戊忠(Wu-Chung Shen)、陳中和(Jeon-Hor Chen)*,Reappraisal on the management and outcome of emphysematous pyelonephritis,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2009 Jan,25(1):16-24
|
Other論文 |
張兆祥(Chang,Chao-Hsiang)、邱昌芳(Chang-Fang Chiu)、吳錫金(Wu,Hsi-Chin)、曾憲彰(Hsien-Chang Tseng)、王仲興(Chung-Hsing Wang)、林正介(Cheng-Chieh Lin)、蔡佳紋(Chia-Wen Tsai)、梁雲(Shiu-Yun Liang)、王政力(Cheng-Li Wang)、包大靝(Da-Tian Bau)*,Significant association of XRCC4 single nucleotide polymorphisms with prostate cancer susceptibility in Taiwan.,MOLECULAR MEDICINE REPORTS,2008 Oct,1(1):525-530
|
SCI論文 |
楊凱甯、陳淑月(Shu-Yueh, Chen)*、陳淑真、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、陳怡靜、鄒頡龍(Chieh-Lung Chou),Sitting and Crouching Over the Public Toilet Seat and Its Effect on Maturation.,INTERNATIONAL UROGYNECOLOGY JOURNAL,2008 Sep,19(Supp1):S77-S78
|
MT論文 |
陳國樑(Kuo-Liang Chen)、蘇百弘(Bai-Horng Su)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、張士三(CHANG S.S.)*,Surveillance of Male Genital Anomalies in Newborns: Experience in a Medical Center in Central Taiwan,Mid-Taiwan Journal of Medicine,2008 Jun,13(2):95-99
|
Other論文 |
黃有志(YU-CHIH HUANG)、張兆祥(Chang,Chao-Hsiang)、王仲興(Chung-Hsing Wang)、張正成(Jeng-Sheng Chang)*,Pheochromocytoma Complicated with Severe Ventricular Tachycardia: Report of One Case,Acta Paediatrica Taiwanica,2007 Oct,48(5):280-294
|
SCI論文 |
黃得韻(Teik-Ying Ng)、楊美都(Mei-Due Yang)*、陳永芳(Yung-Fang Chen)、張兆祥(Chao-Hsiang Chang),Resolution of Hydronephrosis Due to Massive Mesentreic Fibromatosis Using cyclo-oxygenase 2 lnhibitors,UROLOGY,2007 Sep,70(3):591.e3-591.e4
|
MT論文 |
劉緯陽(Wayne Young Liu)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、陳汶吉(Chen Wen-Chi)*,The Role of Retrograde Pyelography for Evaluation of Hematuria in Patients with Normal and Impaired Renal Function,Mid-Taiwan Journal of Medicine,2007 Mar,12(1):14-19
|
SCI論文 |
葉進仲(Jin-Jung Ye)、林殿璜(Tien Huang Lin)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chao-Hsiang Chang)、陳家臻(Chia-Chen Chen)、陳汶吉(Chen Wen-Chi),A High Association of Upper Urinary Tract Transitional Cell Carcinoma with Non-Functioning Kidney Caused by Stone Disease in Taiwan.,UROLOGIA INTERNATIONALIS,2007 ,(79):19-23
|
SCI論文 |
吳錫金(Wu,Hsi-Chin)、張兆祥(Chao-Hsiang Chang)、萬磊(Lei Wan)、吳肇毅(Chao-I Wu)、蔡輔仁(Fuu-Jen Tsai)、陳汶吉(Chen Wen-Chi)*,IL-2 gene C/T polymorphism is associated with prostate cancer.,JOURNAL OF CLINICAL LABORATORY ANALYSIS,2006 Aug,(20):245-249
|
MT論文 |
黃俊寅(Chun-Yin Huang)、許弘昌(Horng-Chaung Hsu)、張兆祥(Chang,Chao-Hsiang)、曾國峰(Kuo-Fung Tseng)、馮逸卿(Yi-Chin Fong)*,Prostate cancer with bone metastases: a clinical profile.,Mid-Taiwan Journal of Medicine,2006 Apr,11(2):82-89
|
SCI論文 |
謝登富(Teng-Fu Hsieh)、張兆祥(Chaog-Hsian Chang)、張士三(Shih-San Chang)*,Foreskin development before adolescence in 2149 schoolboys,INTERNATIONAL JOURNAL OF UROLOGY,2006 ,13(7):968-970
|
MT論文 |
林殿璜、張兆祥(Chao-Hsiang Chang)、葉進仲(Chin-Chung Yeh)、陳武男、張士三(Shi-San Chang)、呂學甫(Hsuen-Fu Lu)、陳昶仲(Chang-Chung Chen)、楊慶鏘(Ching-Chiang Yang)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Wen-Chi Chen)*,Efficacy of extracorporeal shock wave lithotripsy on the treatment of upper urinary tract stones,Mid-Taiwan Journal of Medicine,2005 Jun,10(1):38-42
|
SCI論文 |
陳階曉(CHIEH-HSIAO CHEN)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Chen Wen-Chi)、葉進仲(Jin-Jung Ye)、陳昶仲(chang-chung Chen)、張兆祥(Chao-Hsiang Chang)*,Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma- China Medical Universi ty Hospital experience.,UROLOGY,2005 Apr,65(18):687-691
|
Other論文 |
謝登富(DENG-FU HSIEH)、張兆祥(Chang,Chao-Hsian)、陳汶吉(Chen,Wen-Chi)、鄒頡龍、吳錫金(Wu,His-Chin),Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.,Chinese Medical Journal (Taipei),2005 Apr,68(4):167-171
|
SCI論文 |
吳錫金(Hsi-Chin Wu)、張兆祥(Chao-Hsiang Chang)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai)、蔡進發(Tsai JJP)、陳汶吉(Chen Wen-Chi)*,P53 gene Codon 72 Polymorphism But Not Tumor Necrosis Factor- Gene Is Associated with Prostate Cancer.,UROLOGIA INTERNATIONALIS,2004 Feb,73(2):41-46
|
SCI論文 |
葉進仲、陳階曉(CHIEH-HSIAO CHEN)、(林嘉禾)、張兆祥(Chang,Chao-Hsian)、吳錫金(Wu,His-Chin),A new technique for treating forgotten indwelling ureteral stents: silk loop assisted ureterorenoscopic lithotripsy,JOURNAL OF UROLOGY,2004 ,171():719-721
|
SCI論文 |
吳錫金(Hsi-Chin Wu)、張兆祥(Chao-Hsiang Chang)、陳汶吉(Chen Wen-Chi)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai),Urokinase Gene 3’-UTR T/C Polymorphism Is Not Associated With Bladder Cancer.,GENETICS AND MOLECULAR BIOLOGY,2004 ,27(1):15-16
|
MT論文 |
楊國政(Kuo-Cheng Yang)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chao-Hsiang Chang)、陳國樑(Kuo-Liang Chen)*,The clinical significance of asymtomatic microscopic hematuria.,Mid-Taiwan Journal of Medicine,2003 Dec,8(Suppl 2):S108-S113
|
MT論文 |
陳昶仲(Chang-Chung Chen)、吳錫金(Hsi-Chin Wu)、張兆祥(Chao-Hsiang Chang)、陳汶吉(Wen-Chi Chen)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Eric Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、楊慶鏘(Ching-Chiang Yang)、張士三(CHANG S.S.)*,Comparison of ten TRUS-guided and six sextant prostate biopsy in the prostate cancer detection,Mid-Taiwan Journal of Medicine,2003 Dec,8(Suppl 2):S102-S107
|
Other論文 |
(陳昶仲)、吳錫金(Wu,His-Chin)、張兆祥(Chang,Chao-Hsian)、葉進仲、鄒頡龍、(陳國梁)、楊慶鏘、張士三,十或十二針經直腸超音波攝護腺切片與傳統六針切片對攝護腺癌偵測的比較,中台灣醫學科學雜誌,2003 Nov,8(8):164-167
|
SCI論文 |
張兆祥(Chao-Hsiang Chang)、蕭聿謙(Yu-Chien Shiau)、沈業有(Yeh-You Shen)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Differentiating Solitary Pulmonary Metastases in Patients with Renal Cell Carcinoma by 18F-Fluoro-2-Deocyglucose Positron Emission Tomography – A preliminary Report.,UROLOGIA INTERNATIONALIS,2003 Jul,(71):306-309
|
SCI論文 |
張兆祥(Chang,Chao-Hsian)、吳錫金(Wu,His-Chin)、蔡進發(J.-J.P. Tsai)、林正介(Lin,Cheng-Chieh)、李正淳(Lee,Chun-Cheng)、高嘉鴻(Kao,Chia-Hung)*,Usefulness of technetium-99m hexamethylpropylene amine oxime lung scan to detect subclinical lung injury in patients with chronic renal failure,LUNG,2003 ,181(2):97-101
|
SCI論文 |
張兆祥(Chao-Hsiang Chang)、吳錫金(Wu,Hsi-Chin)、蔡進發(Jeffery J.P. Tsai)、沈業有(Yeh-You Shen)、張賴昇平(Sheng-Pin Changlai)、高嘉鴻(Chia-Hung Kao)*,Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer,UROLOGIA INTERNATIONALIS,2003 ,3(70):311-315
|
SCI論文 |
張兆祥(Chao-Hsiang Chang)、吳錫金(Wu,Hsi-Chin)、(Ruoh-Fang Yeh)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Tissue Polypeptide Specific Antigen (TPS) as a Tumor Marker in Renal Cell Carcinoma,ANTICANCER RESEARCH,2002 Sep,22(5):2949-2950
|
|
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
|
1﹒ |
腎移植後腔室症候群的個案分析及文獻回顧,台灣移植醫學學會2023移植年會暨教育訓練課程暨第二屆台韓交流論壇暨第三屆亞洲胰臟及胰島細胞移植學會會議,台北南港展覽館二館七樓,2023.12.9 ~ 2023.12.10,
|
2﹒ |
METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets,2023 International Conference on Advanced Biomedical Sciences,中國醫藥大學,2023.12.1 ~ 2023.12.2,
|
3﹒ |
Cytoreductive nephrectomy in patients with newly diagnosed metastasis renal cell carcinoma treated with Nivolumab+Cabozantinib,2023 台灣泌尿科醫學會年會,台大國際會議中心,2023.8.19 ~ 2023.8.20,
|
4﹒ |
The role of SPARE nephrometry and tumor contact surface area in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,第110屆日本泌尿外科醫協會年會 (JUA),日本神戶,2023.4.20 ~ 2023.4.23,
|
5﹒ |
未打COVID19疫苗的腎移植病人確診後抗體反應仍不佳,2022台灣內科醫學會會員大會暨學術演講,台大醫院國際會議中心,2022.12.3 ~ 2022.12.4,
|
6﹒ |
台灣的腎臟移植患者注射新冠肺炎疫苗的效度分析,2022台灣移植醫學會年會,南港展覽館,2022.12.10 ~ 2022.12.11,
|
7﹒ |
HCV陰性的腎臟受贈者於接受HCV陽性的大愛腎臟移植術後三小時HCV病毒呈陽性-口服直接抗病毒藥應考慮即早使用,2022台灣移植醫學會年會,南港展覽館,2022.12.10 ~ 2022.12.11,
|
8﹒ |
Tuberculous epididymo-orchitis caused by intravesical bacillus calmette-guérin immunotherapy for bladder cancer: A case report,2022 台灣泌尿科醫學會年會,高雄萬豪酒店,2022.8.20 ~ 2022.8.21,
|
9﹒ |
腫瘤,2021台灣泌尿科醫學會第22屆第2次會員大會暨第43次學術演講會,台中榮民醫院,2021.12.24 ~ 2021.12.26,
|
10﹒ |
,2021台灣泌尿科醫學會第22屆第2次會員大會暨第43次學術演講會-Live Surgery Demo.,台中榮民總醫院,2021.12.24 ~ 2021.12.26,
|
11﹒ |
Update on kindey exchange program of live donor transplantation in western countries,2021台灣泌尿科醫學會第22屆第2次會員大會暨第43次學術演講會,台中榮民總醫院,2021.12.24 ~ 2021.12.26,
|
12﹒ |
Radium-223 for mCRPC: Real-world experience of a single-center,2021 台灣泌尿科醫學會年會,台中榮總,2021.12.25 ~ 2021.12.26,
|
13﹒ |
,台灣尿失禁防治協會110年會員大會暨學術演講會,台北晶華酒店,2021.9.25 ~ 2021.9.26,Update on Pediatric Daytime UI
|
14﹒ |
,Update of urologic oncology(視訊),沙童,2021.5.22 ~ 2021.5.22,
|
15﹒ |
,2021泌尿腫瘤論壇,嘉義長榮,2021.3.6 ~ 2021.3.7,
|
16﹒ |
使用支持向量機分類器最佳化的數學模型協助診斷與偵測磁振造影影像中臨床上有意義之攝護腺癌,中華民國放射線醫學會第三十屆第二次會員大會暨第六十九屆學術研討會,台灣台北,南港展覽館,2020.9.19 ~ 2020.9.19,
|
17﹒ |
Kidney-sparing surgery for upper tract urothelial carcinoma—CMUH experience,2020泌尿科醫學會年會國際場,台大國際會議中心,2020.8.21 ~ 2020.8.23,
|
18﹒ |
The role of tumor contact surface area and SPARE nephrometry in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,2022 International Session of TUA Conference,高雄醫學大學,2020.8.20 ~ 2020.8.20,
|
19﹒ |
Neoadjuvant chemotherapy and adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma,台灣泌尿科醫學會年會,台大,2020.8.21 ~ 2020.8.23,
|
20﹒ |
Dual Kidney Transplantation: the Renal Graft Function Will Improve, Just Like a Sleeping Beauty Worth Waiting for,第三屆全球華人腎臟病學術大會,南京國際青年文化中心,2019.12.5 ~ 2019.12.8,
|
21﹒ |
Peripheral CD4 and CD8 Counts as guidance for Anti-ThymoGlobulin Dosage in Kidney Transplantation—A proposed new approach,Asia Pacific AKI to/on CKD Summit in conjunction with 台灣腎臟醫學會108年會員大會暨學術演講會,台大國際會議中心,2019.11.22 ~ 2019.11.24,
|
22﹒ |
ABO血型不相容活體腎臟移植-中國醫藥大學附設醫院經驗,109年台灣泌尿科醫學會年會,中國醫藥大學,2019.8.16 ~ 2019.8.18,
|
23﹒ |
Adjuvant chemotherapy in T3/T4 upper urinary tract urothelial carcinoma—CMUH experience,台灣泌尿科醫學會年會國際場 ISTUA,中國附醫,2019.8.16 ~ 2019.8.18,
|
24﹒ |
Outcome of lymph node dissection in renal pelvis urothelial carcinoma,台灣泌尿科醫學會年會,中國附醫,2019.8.16 ~ 2019.8.18,
|
25﹒ |
Different features in urinary tract IgG4-related disease: report of two cases,JUA2019 The 107th Annual Meeting of the Japanese Urological Association,Nagoya, Japan.,2019.8.18 ~ 2019.8.21,
|
26﹒ |
Validation of the VIRADS (Vesical Imaging-Reporting and Data System) to identify the muscle invasive urinary bladder cancers,ARRS 2019 Annual Meeting,Hawaii Convention Center, Honolulu, Hawaii.,2019.5.5 ~ 2019.5.10,
|
27﹒ |
Using a combination of keratin 20, GATA3, CD44, and keratin 5/6 immunohistochemical expression in discrimination models for diagnosing luminal and basal urothelial carcinomas,一○八年台灣病理學會暨國際病理學會台灣分會年會,中油大樓國光會議廳 (台北市信義區松仁路3號),2019.5.26 ~ 2019.5.26,
|
28﹒ |
驗證 VI-RADS (膀胱影像 - 報告和數據系統) 找出肌肉浸潤性膀胱癌的效度,中華民國放射線醫學會第三十屆第一次會員大會暨第六十八屆學術研討會,公務人員發展中心福華國際文教會館 (台灣台北),2019.3.23 ~ 2019.3.24,
|
29﹒ |
Association between Urinary Arsenic Profiles and DNA hypomethylation in a Case–Control Study of Urothelial Carcinoma,Environmental Pollution and Health Hazards,Osaka,2018.10.22 ~ 2018.10.23,
|
30﹒ |
Multiparametric Magnetic Resonance Imaging increases predictive accuracy of oncological outcomes after robot-assisted radical prostatectomy,台灣泌尿科醫學會年會,台北榮總,2018.8.18 ~ 2018.8.19,
|
31﹒ |
,Prostate cancer treatment symposium - Central Area,台中林酒店,2017.12.13 ~ 2017.12.13,Clinical experience of using hormone therapy in PCa
|
32﹒ |
Predictive Factors of Necessity of PCN Insertion on Acute Stone Obstructive Pyelonephritis,The 37th Congress of the Societe Internationale d'Urologie,Centro de congressos de lisboa,2017.10.19 ~ 2017.10.22,
|
33﹒ |
,台灣泌尿科醫學會106年中區月會,彰化市建寶街20號,2017.10.21 ~ 2017.10.21,Cytoreductive nephrectomy - update
|
34﹒ |
predictive markers for the prognosis of muscle invasive bladder cancer treated with neoadjuvant chemotherapy,泌尿科醫學會年會,高雄長庚,2017.8.19 ~ 2017.8.20,
|
35﹒ |
,2017臺中攝護祭(民 眾衛教講座),中國醫藥大學 立夫教學大樓 104講堂,2017.6.25 ~ 2017.6.25,何時該接受攝護腺肥大手術,有哪些選擇?
|
36﹒ |
Pure Laparoscopic Nephroureterectomy and Bladder Cuff Excision - CMUH Experience,The 105th Annual Meeting of the Japanese urological association,Hotel Shiroyama, Kagoshima prefectural citizens exchange center, Houzan hall,2017.4.21 ~ 2017.4.24,
|
37﹒ |
Acute Urinary Retention Increases the Risk of Complications after Transurethral Resection of prostate,The 105th Annual Meeting of the Japanese urological association,Hotel Shiroyama, Kagoshima prefectural citizens exchange center, Houzan hall,2017.4.21 ~ 2017.4.24,
|
38﹒ |
CT histogram analysis in predicting size reduction of renal angiomyolipoma after transarterial embolization,The 105th Annual Meeting of the Japanese Urological Association,Hotel Shiroyama, Kagoshima Prefectural Citizens Exchange Center, Houzan Hall,2017.4.21 ~ 2017.4.24,
|
39﹒ |
Comparison the prediective value of nephrometry systems in postoperative split renal function determined by renal scintigraphy: CSA, C-index, P.A.D.U.A., and R.E.N.A.L.,The 105th annual meeting of the Japanese Urological Association,Hotel Shiroyama, Kagoshima Prefectural Citizens Exchange Center, Houzan Hall,2017.4.21 ~ 2017.4.24,
|
40﹒ |
,攝護腺癌學術研討會,台中裕元酒店,2017.3.10 ~ 2017.3.10,Early detection of prostate cancer: Biopsy strategy in patients with previous negative biopsy
|
41﹒ |
,中國 彰基 慈濟 GU Dinner Lecture,與玥樓餐廳,2017.2.21 ~ 2017.2.21,mRCC case sharing
|
42﹒ |
Experience of partial cystectomy in bladder urothelial cancer,WCE 2016,The Cape Town International Convention Centre, Cape Town, South Africa,2016.11.8 ~ 2016.11.12,Oncology: Miscellaneous-Surgical outcomes
|
43﹒ |
Comparison of Treatment of Large Proximal Ureteral Stones Laparoscopic Ureterolithotomy Versus Percutaneous Nephrolithotomy Versus Ureteroscopic Lithotripsy,WCE 2016,The Cape Town International Convention Centre, Cape Town, South Africa,2016.11.8 ~ 2016.11.12,URS outcomes
|
44﹒ |
The relationship among levels of plasma folate, global DNA methylation, and the survival of Urothelialcar cinoma,APACPH 48th Asia-Pacific Academic Consortium for Public Health Conference,日本東京都帝京大學,2016.9.17 ~ 2016.9.19,
|
45﹒ |
Robot-Assisted Anatrophic Nephrolithotomy for complete staghorn stone: case series in China Medical University Hospital,104th Annual Meeting of the Japanese Urological Association,Sendai,2016.4.23 ~ 2016.4.25,Urolithiasis
|
46﹒ |
Evaluation the Relationship and post-operative GFR between the Living Donor and the Recipients in Kidney Transplantation,The 104th annual meeting og the Japanese urological association,Sentai internaltional center conference building, exhibition building, Tohoku university centennial,2016.4.23 ~ 2016.4.25,
|
47﹒ |
Recipient-donor size mismatch and recipient body mass index are associated with decreasing immediate graft function,台灣移植醫學學會 2015 移植年會暨會員大會,台北國際會議中心,2015.11.13 ~ 2015.11.14,
|
48﹒ |
New-onset diabetes after kidney transplantation increased the risk of graft failure and macrovascular complications after kidney transplantation,2015台灣移植醫學年會,台北,2015.11.15 ~ 2015.11.15,
|
49﹒ |
A review of systemic and localized therapy in aRCC,中區泌尿科月會,林酒店_上海廳 (台中市西屯區朝富路99號_台灣大道路口),2015.7.18 ~ 2015.7.18,
|
50﹒ |
Robotic partial nephrectomy (RCC)--- Live demonstration,泌尿腫瘤研討會,台中中國醫學大學附設醫院,2015.6.15 ~ 2015.6.15,
|
51﹒ |
Increased risk of ischemic stroke in patients with chronic kidney disease after recurrent dysnatremia: a nationwide population based cohort study in Taiwan,52nd ERA-EDTA Congress,London, UK,2015.5.28 ~ 2015.5.31,
|
52﹒ |
The concordance between pre-operative MRI and pathology stage in patients with prostate cancer underwent prostatectomy in CMUH,103rd Annual Meeting of the Japanese Urological Association,Kanazawa,2015.4.18 ~ 2015.4.21,Prostate cancer diagnosis
|
53﹒ |
Epidemiology of testicular tumors in Taiwan and subtype review – data from a medical center and Taiwan health insurance database,16th annual congress of Asia Pacific Association of Pediatric Urologists (APAPU 2014) 亞太小兒泌尿醫學會議,Nikko Japan , 日本日光,2014.11.20 ~ 2014.11.22,
|
54﹒ |
,32nd World Congress of Endourology & SWL,Taipei International Convention Center (TICC) NO.1, Hsin-Yi Road, Sec 5, Taipei, Taiwan,2014.9.3 ~ 2014.9.7,
|
55﹒ |
PRIMARY ADRENAL INSUFFICIENCY WITH BILATERAL ADRENAL TUMOR: A CASE REPORT,台灣泌尿科醫學會年會,台北國際會議中心,2014.9.6 ~ 2014.9.7,
|
56﹒ |
Robotic assist rectal GIST resection with radical prostatectomy,32屆世界泌尿內視鏡醫學大會32nd World Congress of Endourology and SWL(WCE 2014),台北國際會議中心,2014.9.3 ~ 2014.9.7,
|
57﹒ |
,High Risk & Locally Advanced Prostate Cancer暨TUA中區泌尿月會,中國醫藥大學立夫教學大樓1樓104講堂,2014.4.19 ~ 2014.4.19,Nuclear Image Study for High Risk and Locally Advanced Prostate Cancer Before Treatment of Tentative Cure
|
58﹒ |
Relationships among theplasma folate, DNMT3A-448A>G polymorphism and urothelial carcinoma,7th General Assembly and International Conference of Asian Pacific Organization for Cancer Preventio,Academia Sinica, Taipei, Taiwan,2014.3.20 ~ 2014.3.23,
|
59﹒ |
使用智慧型手機以及免費通訊軟體即時監控影像尿路動力學-運用於住院醫師教學,102年度標竿學習研討會 第三屆教學優良既教學創新成果經驗分享,中國醫藥大學安康大樓五樓教學部會議室(一),2013.11.9 ~ 2013.11.9,教學創新經驗分享
|
60﹒ |
,PPCS 2013 The 8th Pan-Pacific Contienece society meeting,韓國釜山,2013.9.26 ~ 2013.9.27,CPAP Therapy Improves Stage 1 Sleep Nocturia in Patient with Obstructive Sleep Apnea
|
61﹒ |
,第18屆第2次會員大會暨第35次學術研討會,義守大學燕巢校區,2013.8.31 ~ 2013.9.1,Remote Monitoring of VideourodynamicsUsing Smart Phone and Free Instant Messaging Software
|
62﹒ |
Preliminary Experience with da Vinci-assisted Laparoscopic Radical Prostatectomy in China Medical University Hospital,台灣泌尿科醫學會102年年會,義守大學教樓 義守大學教樓 A棟 1樓,2013.8.31 ~ 2013.8.31,
|
63﹒ |
The effect of cigarette smoking and DNA methyltransferase genes polymorphisms on urothelial carcinoma risk in Taiwan,Environment and Health– Bridging South, North, East and West.,Basel, Switzerland,2013.8.19 ~ 2013.8.23,
|
64﹒ |
,泌尿科中區月會(5月),癌症大樓一樓會議室,2013.5.18 ~ 2013.5.18,達文西機器手臂輔助手術於中國醫藥大學附設醫院泌尿部之經驗
|
65﹒ |
Diagnosis and Treatment of OAB,泌尿先鋒培訓營-中區基層醫療院所,台中永豐棧酒店3樓哈佛廳,2013.4.21 ~ 2013.4.21,
|
66﹒ |
Use MRI to localize prostate cancer before re-biopsy in patients with persistent high PSA and previous negative biopsy,The 4th Asian Congress of Abdominal Radiology,International Academic Research Building,2013.3.22 ~ 2013.3.24,
|
67﹒ |
Low 5-methylcytosine expression as an aggressive biomarker for the urothelial carcinoma: an immunohistochemical study,Molecular Medicine Conference 2012,Mahidol University,2012.12.19 ~ 2012.12.22,
|
68﹒ |
,中區年輕泌尿科醫師學習營,台中Hotel ONE,2012.10.13 ~ 2012.10.13,The Clinical Diagnosis Treatment and Update of OAB
|
69﹒ |
手術前尿路動力學顯示膀胱無收縮或低收縮不會影響婦女尿失禁手術結果,101台灣泌尿科醫學會第34次學術演講會,台大醫學院301會議室,2012.8.19 ~ 2012.8.19,婦女泌尿及尿路動態
|
70﹒ |
THE MUTUAL EFFECTS BETWEEN RENAL TRAUMA AND URETERAL STONE,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.8.17 ~ 2012.8.18,
|
71﹒ |
MANAGEMENT OF ENCASEMED AORTA AND INFERIOR VENA CAVA TO THE RETROPERITONEAL TUMOR: A CASE REPORT,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.8.17 ~ 2012.8.18,
|
72﹒ |
THE INITIAL MANIFESTATION OF RENAL CELL CARCINOMA IS PULMONARY EMBOLISM: A CASE REPORT,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.8.17 ~ 2012.8.18,
|
73﹒ |
,101年度台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.8.18 ~ 2012.8.19,
|
74﹒ |
,攝護腺癌病友座談會暨成立大會,中國醫藥大學附設醫院 學校 立夫教學大樓1樓 103教室,2012.7.29 ~ 2012.7.29,攝護腺癌你、我、他--- 攝護腺癌病友會成立大會
|
75﹒ |
,膀胱腫瘤研討會,台中市大墩11街386號,2012.6.2 ~ 2012.6.2,Case sharing (BCG)
|
76﹒ |
,Post ELITE Seminar(中區泌尿科研討會),台中市大富街6 號,2012.5.18 ~ 2012.5.18,Lower Urinary Tract Symptoms due to BPH
|
77﹒ |
The application of Diffusion weighted MR Imaging in Diagnosing T Stage of Urinary Bladder Cancer 水分子擴散影像做膀胱癌的診斷分期之應用,一○一年度第二十七屆第三次會員大會暨第六十一次學術研討會,台大醫院國際會議中心,2012.3.24 ~ 2012.3.25,
|
78﹒ |
Prostate cancer: What's new in 2001 after EAU and AUA,Current advances in Prostate Cancer Treatment,台中亞緻大飯店27F,2011.10.1 ~ 2011.10.1,
|
79﹒ |
Evaluation of low urinary tract symptoms and life quality in the patient with urothelial carcinoma in bladder underwent radical cystectomy with orthotopic neobladder,泛太平洋尿控制協會年會(PPCS),台北榮總,2011.9.23 ~ 2011.9.24,
|
80﹒ |
MENINGITIS-RETENTION SYNDROME: A CASE REPORT,台灣泌尿科醫學會年會,台南成大醫學院,2011.8.13 ~ 2011.8.14,
|
81﹒ |
METACHRONOUS CANCER OF THE HEAD AND NECK AND THE URINARY TRACT,台灣泌尿科醫學會年會,台南成大醫學院,2011.8.13 ~ 2011.8.14,
|
82﹒ |
Urinating in the Standing Position: A Feasible Alternative for Elderly Women With Knee Osteoarthriti,台灣泌尿科醫學會年會,台南成大醫學院,2011.8.13 ~ 2011.8.14,
|
83﹒ |
Evaluation of low urinary tract symptoms and life quality in the patient with urothelial carcinoma in bladder s/p radical cystectomy with studer pouch reconstruction,台灣泌尿科醫學會年會,台南成大醫學院,2011.8.13 ~ 2011.8.14,
|
84﹒ |
Development of Nomorgram to Predict Pathologic outcome of radical prostatectomy for localized prostate cancer base on Taiwanese data. Annual meeting of Tiawan Urological Association.,台灣泌尿科醫學會2011年年會,成大,2011.8.13 ~ 2011.8.14,
|
85﹒ |
Tricks and pitfalls of laparoscopic surgery,TUA100年泌尿科住院醫師核心課程講座,中國附醫癌症中心1F階梯教室,2011.7.23 ~ 2011.7.24,
|
86﹒ |
The genetic role of cyclooxygenase 2 in Taiwan prostate cancer patients,第二屆調適醫學聯合學術年會,臺北市立體育學院,2011.4.9 ~ 2011.4.10,
|
87﹒ |
Associations of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer,第 26 屆生物醫學聯合學術年會,國防醫學院致德廳一樓,2011.3.19 ~ 2011.3.20,
|
88﹒ |
Urinate in the Standing Position: a Feasible Alternative for Elderly Woman with Knee Osteoarthritis,台灣外科醫學會第二十二屆第二次會員代表大會暨第70次學術研討會,台北醫學大學醫學綜合大樓前棟一樓,2011.3.19 ~ 2011.3.20,Urinate in the Standing Position: a Feasible Alternative for Elderly Woman with Knee Osteoarthritis
|
89﹒ |
,亞洲暨台灣泌尿科年會,台北國際會議中心,2010.8.27 ~ 2010.8.31,
|
90﹒ |
Update on the treatment strategy of LAPC,Update on LPC & LAPC,台中金典 13F 菁英二廳,2010.7.17 ~ 2010.7.17,Controversy in LAPC treatment
|
91﹒ |
單一切口腹腔鏡手術在泌尿科領域之應用,99年04月中區泌尿科月會,中國醫藥大學附設醫院 癌症中心大樓1樓階梯教室(台中市北區學士路6號),2010.4.24 ~ 2010.4.24,The Applications of Transumbilical Single-Incision Laparoscopic Surgery (SILS) in Urology Field
|
92﹒ |
WOMEN URINATE IN THE STANDING POSITION DO NOT INCREASE POST-VOID RESIDUAL URINE VOLUMES,台灣婦女泌尿暨骨盆醫學會(TUGA)論文發表會,台北 新北投龍邦橋園會館5樓會議室,2009.12.26 ~ 2009.12.27,
|
93﹒ |
Salvage Penile Curvature Correction Surgery,12th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine,新加坡Singapore,2009.12.12 ~ 2009.12.15,
|
94﹒ |
Penile veins are the Determining Contributor for Erection: The Hemodynamic Evidence from the Study in Defrosted Human Cadavers,12th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine,新加坡Singapore,2009.12.12 ~ 2009.12.15,
|
95﹒ |
Clinical Experience of a Refined Penile Venous Stripping Surgery Procedure for Patients with Erectile Dysfunction: Is It a Viable Option?,12th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine,新加坡Singapore,2009.12.12 ~ 2009.12.15,
|
96﹒ |
A Physiological Approach to a Penile Venous Stripping Surgical Procedure for Patients with Erectile Dysfunction,12th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine,新加坡Singapore,2009.12.12 ~ 2009.12.15,
|
97﹒ |
Salvaging Penile Venous Stripping Surgery,12th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine,新加坡Singapore,2009.12.12 ~ 2009.12.15,
|
98﹒ |
LOWER URINARY TRACT SYMPTOMS IN THE PATIENTS WITH DEPRESSION OR ANXIETY,第四屆泛太平洋尿控制學會年會,日本福岡,2009.9.10 ~ 2009.9.10,
|
99﹒ |
Spontaneous Rupture of Conventional Renal Cell Carcinoma,台灣泌尿科醫學會2009年學術演講會,高雄榮總,2009.8.29 ~ 2009.8.30,
|
100﹒ |
LOWER URINARY TRACT SYMPTOMS IN THE PATIENTS WITH DEPRESSION OR ANXIETY,98台灣泌尿科醫學會年會,高雄榮總,2009.8.28 ~ 2009.8.29,
|
101﹒ |
Depression, anxiety and LUTS,2009 台灣LUTS研究高峰會,花蓮慈濟醫院,2009.8.15 ~ 2009.8.15,
|
102﹒ |
DOES PARTIAL CATHETER REPLACEMENT BECOME A FINAL TECHNIQUE TO OVERCOME P.D. TUNNEL INEFCTION TO MAINTAIN CATHETER SET FUNCTIONING?,98年度台灣泌尿科醫學會年會,高榮,2009.8.29 ~ 2009.8.30,
|
103﹒ |
IS IT POSSIBLE FOR PERITONEAL DIALYSIS UREMIC PATIENTS WHO CONTINUE TO DO P.D. AT PERI-NEPHRECTOMY PERIOD?,98年度台灣泌尿科醫學會年會,高榮,2009.8.29 ~ 2009.8.30,
|
104﹒ |
Comparison the difference about the clinical presentations between one stage and two stage percutaneous nephrostomy lithotripsy.,98年度台灣泌尿科醫學會年會,高榮,2009.8.29 ~ 2009.8.30,
|
105﹒ |
以創新性單一傷口腹腔鏡膀胱切開取石手術及人工網膜疝氣修補手術治療一罕見巨大膀胱結石合併單側腹股溝疝氣:一病例報告(Vedio presentation),98年第16屆第2次會員大會暨第31次學術演講會,高雄榮民總醫院(高雄市大中一路386號,2009.8.29 ~ 2009.8.30,以創新性單一傷口腹腔鏡膀胱切開取石手術及人工網膜疝氣修補手術治療一罕見巨大膀胱結石合併單側腹股溝疝氣:一病例報告
|
106﹒ |
Association of oral cancer susceptibility and DNA double strand break gene Ku70 single nucleotide polymorphisms,第二屆全球口腔癌症醫學研討會議,加拿大多倫多Sheraton Centre大飯店會議廳,2009.7.8 ~ 2009.7.11,
|
107﹒ |
Oral cancer susceptibility is associated with XRCC4 polymorphisms, smoking and betel quid chewing,第二屆全球口腔癌症醫學研討會議,加拿大多倫多Sheraton Centre大飯店會議廳,2009.7.8 ~ 2009.7.11,
|
108﹒ |
Oral cancer susceptibility, metastasis, and recurrence in relation to Tenascin C genotypes,第二屆全球口腔癌症醫學研討會議,加拿大多倫多Sheraton Centre大飯店會議廳,2009.7.8 ~ 2009.7.11,
|
109﹒ |
Effects of Gene-environmental Interaction of Ku80 with Areca Chewing on Oral Cancer Susceptibility in Taiwan,第二屆全球口腔癌症醫學研討會議,加拿大多倫多Sheraton Centre大飯店會議廳,2009.7.8 ~ 2009.7.11,
|
110﹒ |
Significant Association of XRCC4 Genotypes with Prostate Cancer Risk in Taiwan,2009年研究學習群期末成果發表會,立夫教學大樓105講堂,2009.6.5 ~ 2009.6.5,
|
111﹒ |
Significant Association of XRCC4 Polymorphisms with Prostate Cancer Risk in Taichung,第二十四屆生物醫學聯合學術年會,國防醫學院內湖院區,2009.3.21 ~ 2009.3.22,
|
112﹒ |
Genetic-environmental Joint Effects of Ku80 with Areca Chewing on Oral Cancer Risk in Taiwan,第二屆中國醫藥大學暨亞洲大學生物科技研討會,立夫教學大樓B1國際會議廳,2009.3.16 ~ 2009.3.16,
|
113﹒ |
Association of Oral Cancer Susceptibility and Double Strand Break Gene Ku70 Polymorphisms in Taichung,第24屆生物醫學聯合學術年會,國防醫學院內湖院區,2009.3.21 ~ 2009.3.22,
|
114﹒ |
Significant Association of XRCC4 Genotypes with Prostate Cancer Risk in Taiwan,第二屆中國醫藥大學暨亞洲大學生物科技研討會,立夫教學大樓B1國際會議廳,2009.3.16 ~ 2009.3.16,
|
115﹒ |
Effects of Genetic-environmental Interaction of Ku80 with Areca Chewing on Oral Cancer Susceptibility in Taiwan,第24屆生物醫學聯合學術年會,國防醫學院內湖院區,2009.3.21 ~ 2009.3.22,
|
116﹒ |
Association of Double Strand Break Gene Ku70 Polymorphisms with Oral Cancer Risk in Taichung,第二屆中國醫藥大學暨亞洲大學生物科技研討會,立夫教學大樓B1國際會議廳,2009.3.16 ~ 2009.3.16,
|
117﹒ |
ADAM9 upregulation induce prostate cancer progression and the possible therapeutic application,Advances in Prostate Cancer Research,San Diego, California, USA,2009.1.21 ~ 2009.1.24,
|
118﹒ |
The evaluation of lower urinary tract symptoms and urodynamic studies in the patients with lumber intervertebral disk protrusion underwent decompressiVE surgery: short-term result.,Annual meeting of Orthopedic Association,林口長庚,2008.10.25 ~ 2008.10.26,
|
119﹒ |
Sitting and Crouching Over the Public Toilet Seat and Its Effect on Maturation,International Urogynecological Association 33rd Annual Meeting,Taipei International Convention Center(TICC) Taipei, Taiwan,2008.9.13 ~ 2008.9.17,
|
120﹒ |
VOIDING DYSFUNCTION IN MENTALLY DISABLED CHILDREN,第三屆泛太平洋尿控協會年會,高雄長庚醫院,2008.9.26 ~ 2008.9.27,
|
121﹒ |
THE ROLE OF HISTOLOGICAL ANALYSIS OF CIRCUMCISION SPECIMENS,97年台灣泌尿科醫學會年會,輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
122﹒ |
COMPARISON OF RRP AND LRRP: A FOLLOW-UP OF 86 PATIENTS-CMUH EXPERIMENTS,97年度台灣泌尿科醫學會年會,輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
123﹒ |
DEVELOPMENT OF WEB-BASED ONLINE ANALYSIS AND DECISION SYSTEM PLATFORM FOR CLINICAL INFOMETRICS FOR PROSTATE CANCER (CIPC) AND QUALITY OF LIFE MEASUREMENT,97年度台灣泌尿科醫學會年會,輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
124﹒ |
LAPAROSCOPIC PARTIAL CYSTECTOMY FOR BLADDER TCC WITH MUSCLE INVASION– A CASE REPORT,97年度泌尿科醫學會年會,輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
125﹒ |
Comparison of RRP and LRRP: a follow-up of 66 patients- CMCH Experiments,台灣泌尿科年會 ( 97年),台北輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
126﹒ |
OUTCOMES ANALYSIS OF HAND-ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY VERSUS PURE LAPAROSCOPIC NEPHROURETERECTOMY FOR MANAGING UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA—CHINA MEDICAL,2008臺灣泌尿科醫學會年會,輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
127﹒ |
攝護腺癌臨床資訊暨生活品質測量線上分析決策系統之資訊網路平台開發,台灣泌尿科醫學會第30次學術演講會,輔仁大學醫學院,2008.8.30 ~ 2008.8.31,
|
128﹒ |
Prostate Cancer Susceptibility is Associated with a Novel XPD Polymorphism in Taiwanese Patients.,2008 International Conference on Biomedicine & Graduate Student Retreat,中國醫藥大學立夫教學大樓B1 國際會議廳,2008.5.1 ~ 2008.5.2,
|
129﹒ |
A Novel Single Nucleotide Polymorphism in XPD Gene is Associated with Prostate Cancer in Central Taiwan Patients,第一屆中國醫藥大學生物科技研討會,立夫大樓B1國際會議廳,2008.4.7 ~ 2008.4.7,
|
130﹒ |
Primitive Neuroectodermal Tumor in Horseshoe Kidney,台灣外科醫學會第二十一屆第一次會員代表大會暨第六十七次聯合學術研討會,高雄榮民總醫院,2008.3.29 ~ 2008.3.30,
|
131﹒ |
Association of XPD Polymorphisms with Prostate Cancer in Taiwanese Patients,第23屆生物醫學聯合學術年會,國防醫學院內湖院區,2008.3.29 ~ 2008.3.30,
|
132﹒ |
Voiding dysfunction in mentally disabled children,台灣外科醫學會 2008年年會,高雄榮民總醫院,2008.3.29 ~ 2008.3.30,
|
133﹒ |
Routine Biopsy for the Upper Urinary Tract Malignancy in Patients with Staghorn Stone,23th Annual EAU Congress,Milan, Italy,2008.3.26 ~ 2008.3.29,
|
134﹒ |
Association of XPD Polymorphisms with Prostate Cancer in Taiwanese Patients,第一屆國際癌症學術研討會,立夫教學大樓國際會議廳,2007.11.16 ~ 2007.11.17,
|
135﹒ |
The evaulation of lower urinary tract symptoms and urodynamic studies in the patients with lumbar intervertebral disk protrudion underwent decompressive surgery,: short-term result,第二屆泛亞太平洋尿失禁協會年會,韓國首爾,2007.10.19 ~ 2007.10.19,
|
136﹒ |
,男性下泌尿道功能研討會,台中金典酒店會議廳,2007.9.22 ~ 2007.9.22,Male LUTS: Terminology Pathophysiology Medical Treatment
|
137﹒ |
Radical Cystectomy in Elderly: Clinical Result and Long-term Follow-up,台灣泌尿科醫學會96年度第29次學術演講會,台中榮總,2007.8.25 ~ 2007.8.26,
|
138﹒ |
Superfical Urinary Bladder Urolthelial Carcinoma in Uremic Patients,台灣泌尿科醫學會96年度第29次學術演講會,台中榮總,2007.8.25 ~ 2007.8.26,
|
139﹒ |
External Genital Screen for the Male Newborns in China Medical University Hospital,台灣泌尿科醫學會96年年會,台中市,2007.8.25 ~ 2007.8.26,
|
140﹒ |
THE EVALUATION OF LOWER URINARY TRACT SYMPTOMS AND URODYNAMIC STUDIES IN THE PATIENTS WITH LUMBER INTERVERTEBRAL DISK PROTRUSION UNDERWENT DECOMPRESSIVE SURGERY: SHORT-TERM RESULT,台灣泌尿科醫學會 96年年會,台中榮總,2007.8.25 ~ 2007.8.26,
|
141﹒ |
Pelvic floor muscle EMG spectral analysis in the patient receiving external urethral sphincter Botulinum toxin injection,台灣泌尿科醫學會年會,中榮,2007.8.25 ~ 2007.8.26,骨盆底肌肉肌電圖頻譜分析在尿道外括約接受肌肉毒桿菌素注射患者的應用
|
142﹒ |
Initial 40 experiences of The Potassium-Titanyl-Phosphate Laser Vaporization Prostatectomy,台灣泌尿科醫學會年會,中榮,2007.8.25 ~ 2007.8.26,
|
143﹒ |
骨盆底肌肉肌電圖頻譜分析在尿道外括約肌接受肉毒桿菌素注射患者的應用,2007臺灣泌尿科醫學會年會,台中榮總,2007.8.25 ~ 2007.8.26,
|
144﹒ |
腎臟血管平滑肌脂肪瘤的預後評估-中國醫藥大學的經驗,2007臺灣泌尿科醫學會年會,台中榮總,2007.8.25 ~ 2007.8.26,
|
145﹒ |
以經尿道肉毒桿菌素注射膀胱頸治療年紀小於50歲之原發性膀胱頸阻塞病人:短期報告,台灣外科醫學會年會,台灣高雄(榮總),2007.3 ~ ,
|
146﹒ |
Using Transurethral Botulinum Toxin Injection Of Bladder Neck For The Treatment Of Primary Bladder Neck Obstruction In Men Less Than 50 Years Of Age: Short-Term Result,中華民國外科醫學會2007年年會,高雄榮總,2007.3.24 ~ 2007.3.25,
|
147﹒ |
Using Transurethral Botulinum Toxin Injection Of Prostate For The Treatment Of Benign Prostate Hyperplasia: Short-Term Result,第一屆泛太平洋下泌尿道功能障礙研討會,日本東京,2006.9.6 ~ 2006.9.6,
|
148﹒ |
Using transurethral botulinum toxin injection of prostate for the treatment of benign prostate hyperplasia: short-term result,泛太平洋尿控制協會2006年會,日本 /東京,2006.9.5 ~ 2006.9.6,
|
149﹒ |
USING TRANSURETHRAL BOTULINUM TOXIN INJECTION OF PROSTATE FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA: SHORT-TERM RESULT,95年泌尿科年會,台灣,2006.8.23 ~ 2006.8.24,USING TRANSURETHRAL BOTULINUM TOXIN INJECTION OF PROSTATE FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA: SHORT-TERM RESULT
|
150﹒ |
The efficacy of emergent embolizaton of internal iliac artery for severe hemorrhagic radiation cystitis,台灣泌尿科醫學會年會,台灣台北,2006.8 ~ ,
|
151﹒ |
The surgical results of renal cell carcinoma at CMUH,台灣泌尿科醫學會年會,台灣台北,2006.8 ~ ,
|
152﹒ |
Camparison of open and laparoscopic bilateral nephroureterectomy and cystectomy in uremic patients,台灣泌尿科醫學會年會,台灣台北,2006.8 ~ ,
|
153﹒ |
尿毒症病人的續發性對側上泌尿道泌尿上皮癌,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
154﹒ |
Using transurethral botulinum toxin injection of prostate for the treatment of benign prostate hyperplasia: short-term result,泛太平洋尿控制協會年會,日本東京,2006.8 ~ ,
|
155﹒ |
Subsequent contralateral upper urinary tract urothelial carcinoma in uremic patients,95年台灣泌尿科醫學會年會,TaiwanTaipei,2006.8 ~ ,
|
156﹒ |
Outcome of the urinary bladder after bilateral nephroureterectomy in uremic patients with urothelial carcinoma,95年台灣泌尿科醫學會年會,TaiwanTaipei,2006.8 ~ ,
|
157﹒ |
An aged female urethra inverted papilloma — case report,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
158﹒ |
Outcome of the Urinary Bladder after Bilateral Nephroureterectomy
in Uremic Patients with Urolthelial Carcinoma,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
159﹒ |
Four-corner autologous rectus fascia sling procedure for repair of anterior vaginal prolapse,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
160﹒ |
Successful ureteroscopic treatment of spontaneous ureteral rupture — 3 cases report,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
161﹒ |
Left ectopic ureteral orifice located on the bladder neck- internal sphincter: case report,台灣泌尿科醫學會95年年會(,台灣台北,2006.8 ~ ,
|
162﹒ |
Biopsy of renal pelvis during the percutaneous nephrolithotripsy session,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
163﹒ |
Using transurethral Botulinum Toxin injection of prostate for the treatment of benign Prostate Hyperplasia: shout-term result,台灣泌尿科醫學會95年年會,台灣台北,2006.8 ~ ,
|
164﹒ |
Using Transurethral Resection Of Prostate And Botulinum Toxin Injection Of External Sphincter For The Treatment Of Benign Prostate Hyperplasia And Detrusor-Sphincter Dyssynergia,95年泌尿科年會,高雄榮總,2006.8.25 ~ 2006.8.26,
|
165﹒ |
The surgical results of renal cell carcinoma at CMUH,台灣泌尿科醫學會年會(國內/台灣 /台北) Aug-06,國內/台灣 /台北,2006.8.5 ~ 2006.8.6,
|
166﹒ |
Botulinum-A Toxin Injections For the Treatment of Lower Urinary Tract Symptoms,台灣泌尿科醫學會 6月份中區月會,中國醫藥大學附設醫院,2006.6.24 ~ 2006.6.24,
|
167﹒ |
Combined Botulinum-A Toxin Injections on the External Urethral Sphincter and TURP for the Treatment for the Patients with BPH and HIVD,中華民國外科醫學會2006年年會,林口 長庚醫學院,2006.3.26 ~ 2006.3.27,
|
168﹒ |
Using transurethral resection of prostate and botulinum toxin injection of external sphincter for the treatment of benign prostate hyperplasia and detrusor-sphincter dyssynergia,台灣外科醫學會年會,台灣桃園,2006.3 ~ ,
|
169﹒ |
The result of calycoureterostomy: follow up-cases report,台灣外科醫學會年會,台灣台北,2006.3 ~ ,
|
170﹒ |
Botulinum-A Toxin injections on the external urethral sphincter as a treatment for voiding dysfunctionof women,台灣尿失禁防治協會及中華民國婦女泌尿暨骨盆鬆弛醫學會聯合年會,台灣台北市,2005.12 ~ ,
|
171﹒ |
Cerebrovascular accident and urine retention: a prospective correlation of the site of brain injury with urodynamic studies,The 2nd Japan - Korea joint meeting on lower urinary tract dysfucntion,韓國首爾,2005.10 ~ ,
|
172﹒ |
Cerebrovascular accident and urine retention: prospective correlation of the site of brain injury with urodynamic studies,日、韓聯合下尿路功能障礙研討會2005 年年會,韓國 首爾,2005.10.24 ~ 2005.10.24,
|
173﹒ |
RADICAL CYSTECTOMIES: A REVIEW OF CHINA MEDICAL UNIVERSITY EXPERIENCE,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.8 ~ ,
|
174﹒ |
CHARACTERISTIC PATTERNS ON MASS SPECTROSCOPY OF PROTEINS EXTRACTED FROM CALCIUM OXALATE STONES,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.8 ~ ,
|
175﹒ |
FORESKIN DEVELOPMENT BEFORE ADOLESCENCE IN SCHOOL BOYS,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.8 ~ ,
|
176﹒ |
CYSTECTOMIES IN UREMIA PATIENTS: WHAT IS DIFFERENCE,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.8 ~ ,
|
177﹒ |
Incidental upper urinary tract malignancy found in non-function kidney caused by urolithiasis,World congress on Endourology & ESWL,荷蘭陳姆斯特丹,2005.8 ~ ,
|
178﹒ |
Incidental upper urinary tract malignancy found in non-function kidney caused by urolithiasis,23rd World Congress on Endourology and SWL 21st Basic Research Symposium,荷蘭阿姆斯特丹,2005.8 ~ ,
|
179﹒ |
Prevalence study of ault hypogonadism in taiwan.,94年台灣男性學醫學會年會,台灣台北,2005.3 ~ ,
|
180﹒ |
Laparoscopic Radical Prostatectomy:CMUH Initial Experience,台灣外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
181﹒ |
Prevalence Study of Adult Hypogonadism in Taiwan,台灣外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
182﹒ |
Prevlence Study of adult Hypogonadism in Taiwan,94年度台灣男性學醫學會,台灣台北,2005.3 ~ ,
|
183﹒ |
Laparoscopic nerve sparing radical prosatectomy,94年度台灣男性學醫學會年會,台灣台北,2005.3 ~ ,
|
184﹒ |
Bilateral testicular infarction due to thromboembolism of lung cancer,94年外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
185﹒ |
Posterior sub-tenon's triamcinolone acetonide for retinal vein occlusion,20th asia pacific academy of ophthalmology congress,馬來西亞吉隆坡,2005.3 ~ ,
|
186﹒ |
Bilateral testicular infarction due to thromboembolism of lung cancer,94年外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
187﹒ |
Gangrenous cystitis : case report,94年外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
188﹒ |
The use of self-made prolene mesh sling for the treatment of patients with strress urinary incontinence,外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
189﹒ |
Extrarenal malignant rhabdoid tumor from omentum in an adult : case report,94年外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
190﹒ |
Laparoscopic radical prostatectomy : China Medical Univirsity Hospital initial experience,94年外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
191﹒ |
Antireflux Surgery of Vesicoureteral Reflux : Experience in China Medical University Hospital,94年台灣外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
192﹒ |
Gangrenous cystitis : case report,94年外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
193﹒ |
Extrarenal malignant rhabdoid tumor from omentum in an adult : case report,94年外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
194﹒ |
The Surgical Treatment for adrenal tumor causing cushing's syndrome,94年外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
195﹒ |
Laparoscopic radical prostatectomy : China Medical Univirsity Hospital initial experience,94年外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
196﹒ |
Risk Adjustment for evaluating the outcome of urological operation,94年外科醫學會年會,台灣台北縣,2005.3 ~ ,
|
197﹒ |
Antireflux surgery of vesicoureteral reflux : experience in China Medical University Hospital,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,長庚大學,2005.3.27 ~ 2005.3.27,
|
198﹒ |
The Surgical Treatment for adrenal tumor causing cushing's syndrome,94年外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
199﹒ |
Risk adjustment for evaluating the outcome of urological operation,94年外科醫學會年會,台灣桃園縣,2005.3 ~ ,
|
200﹒ |
THE USE OF SELF-MADE PROLENE MESH SLING FOR THE TREATMENT OF PATIENTS WITH STRESS URINARY INCONTINENCE,94年外科醫學會年會,長庚醫學大學,2005.3.26 ~ 2005.3.27,
|
201﹒ |
Using alpha adrenergic antagonists and urethral sounding for the treatment of bladder outlet obstruction of women,台灣尿失禁防治協會及中華民國婦女泌尿暨骨盆鬆弛醫學會聯合年會,台灣台北,2004.10 ~ ,
|
202﹒ |
The experience of laparoscopic surgery for the suprarenal lesions in the cmuh.,93年泌尿科年會醫學會,台灣台北,2004.8 ~ ,
|
203﹒ |
Using alpha adrenergic antagonists and urethral sounding for the treatment of bladder outlet obstruction of women.,93年台灣泌尿科醫學會,台灣台北,2004.8 ~ ,
|
204﹒ |
Right perirenal and retroperitoneal fluid collection: suspected pancreatic pseudocyst rupture--case report.,93年泌尿科年會暨醫學會,台灣台北,2004.8 ~ ,
|
205﹒ |
Case report: accessory spleen Mimics a left adrenal tumor.,台灣泌尿科醫學會93年度大會,台灣台北,2004.8 ~ ,
|
206﹒ |
Pure laparoscpic left live donor nephrectomy-initial experience and its technical consideration.,93年泌尿科年會暨醫學會,台灣台北,2004.8 ~ ,
|
207﹒ |
Left xanthogranulotamous pyelonephritis with left-sided inferior vena cava: report of a case.,93年台灣泌尿科醫學會年會,台灣台北,2004.8 ~ ,
|
208﹒ |
Laparoscopic ureteroureterostomy for retrocaval ureter.,93年台灣泌尿科醫學會年會,台灣台北,2004.8 ~ ,
|
209﹒ |
USING ALPHA ADRENERGIC ANTAGONISTS AND URETHRAL SOUNDING FOR THE TREATMENT OF BLADDER OUTLET OBSTRUCTION OF WOMEN,93年台灣泌尿科醫學會年會,中國醫藥大學,2004.8.28 ~ 2004.8.29,
|
210﹒ |
RIGHT PERIRENAL AND RETROPERITONEAL FLUID COLLECTION:,泌尿外科醫學會年度學術討論會,中國醫藥大學,2004.8.28 ~ 2004.8.29,
|
211﹒ |
The use of in situ anterior vaginal wall sling for the treatment of grade III-IV cystocele with stress urinary incontinence,九十三年外科醫學會,台灣台北,2004.3 ~ ,
|
212﹒ |
Renal transplantation: limited experience from CMUH,九十三年外科醫學會,台灣台北,2004.3 ~ ,
|
213﹒ |
Low dose dexamethasone therapy for hormone refractory prostate cancer,九十三年外科醫學會,台灣台北,2004.3 ~ ,
|
214﹒ |
Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction: initial experience,九十三年外科醫學會,台灣台北,2004.3 ~ ,
|
215﹒ |
Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction: initial experience,93年度台灣外科醫學會,台灣台北,2004.3 ~ ,
|
216﹒ |
Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction: initial experience.,93年度台灣外科醫學會,台灣台北,2004.3 ~ ,
|
217﹒ |
New technique treated forgotten indwelling ureteral stent with silk-loop fixed its low end ,台灣泌尿科醫學會,,2003.8 ~ ,
|
218﹒ |
Use of genetic algorithms and artificial neural networks to the prediction of stone disease by clinical parameters and genetic polymorphisms ,台灣泌尿科學會,,2003.8 ~ ,
|
219﹒ |
Neoadjuvant Androgen Deprivation and Definitive Radiotherapy in Localized and Locally Advanced Prostate Cancer,台灣泌尿科醫學會,,2003.8 ~ ,
|
220﹒ |
Transitional cell carcinoma in uremic patients,台灣泌尿科醫學會,,2003.8 ~ ,
|
221﹒ |
Congenital Ureteropelvic Junction Obstruction: Experience in CMUH.,台灣泌尿科醫學會92年會員大會,中國醫藥大學,2003.8.30 ~ 2003.8.31,
|
222﹒ |
Recurrent tumor of carcinosarcoma of renal pelvis which developed from the sarcomatous element only ,台灣泌尿科醫學會,,2003.8 ~ ,
|
223﹒ |
Prognostic Factors of Biochemical Failure after Radical Prostatectomy.,台灣泌尿科醫學會92年會員大會,中國醫藥大學,2003.8.30 ~ 2003.8.31,
|
224﹒ |
The applied evaluation of retrograde pyelographyhe for patients with hematuria ,台灣泌尿科醫學會,,2003.8 ~ ,
|
225﹒ |
Paclitaxel (Taxol) induced G2/M arrest of cell cycle in human bladder cancer cell line (T24) ,台灣泌尿科醫學會,,2003.8 ~ ,
|
226﹒ |
Laparoscopic surgery for upper urinary tract tcc-preliminary experiences in china medical college hospital ,台灣泌尿科醫學會,,2003.8 ~ ,
|
227﹒ |
Surgery treatment for upper urinary tract TCC,台灣泌尿科醫學會,,2003.8 ~ ,
|
228﹒ |
Comparison with Incidental Detected and Symptomatic Renal Cell Carcinoma.,台灣泌尿科醫學會92年會員大會,中國醫藥大學,2003.8.30 ~ 2003.8.31,
|
229﹒ |
Myocardial insult and Ventricular tachycardia in an eleven-year-old girl of Pheochromocytoma,台灣兒科醫學會174屆學術演講會,台灣台北,2003.4 ~ ,
|
230﹒ |
Leiomyoma of the bladder neck—An unusual cause of difficult voiding.,中華民國泌尿科醫學會92年會員大會,北榮,2002.8.24 ~ 2002.8.25,
|
231﹒ |
The Possibility of Anterior Calyx to Be an Access of PCN or PCNL,台灣外科醫學會92年會員大會,高醫,2002.3.23 ~ 2002.3.23,
|
232﹒ |
Assessment of the Change in Life Quality and in Sexual Activities of the Female Patient Before and after Operation for Stress Urinary Incontinence.,台灣外科醫學會92年會員大會,高醫,2002.3.24 ~ 2002.3.24,
|
233﹒ |
Experience of Pubovaginal Sling Suspension in Treatment of Stress Urinary Incontinence.,台灣外科醫學會92年會員大會,高醫,2002.3.24 ~ 2002.3.24,
|
234﹒ |
Asymptomatic Microscopic Hematuria Is Full Urological Examination Needed?,外科醫學會,高醫,2002.3.23 ~ 2002.3.23,
|
235﹒ |
Long term results of Pubo-vaginal rectus fasical slings for female stress urinary,泌尿科醫學會年會,北榮,1998.8.23 ~ 1998.8.24,
|
236﹒ |
The pubo-vaginal rectus fascial slings for female stress urinary incontinence,泌尿科醫學會年會,北榮,1997.8.23 ~ 1997.8.24,
|
|
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
|
1﹒ |
個別型,無,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、楊啟瑞(Chi-Rei Yang)、楊美都(Mei-Due Yang)、謝明家、方信元(Hsin-Yuan Fang)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、張維君(Wei-Chun Chang)、葉士芃(Shih-Peng Yeh)、劉良智(Liang-Chih Liu)、柯道維(Tao-Wei Ke)、林振源(Lin, Chen-Yuan)、陳自諒(Tzu-Liang Chen)、張兆祥(Chao-Hsiang Chang)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林文元(Wen-Yuan lin)、花俊宏(Chun-Hung Hua)、孟乃欣(Nai-Hsin Meng)、王約翰(John Wang)、徐華穗(Hua-Shai Hsu)、蔡伯邦(Po-Pang Tsai)、陳育傑(Yu-Chieh Chen)、王帝皓(Ti-Hao Wang)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh)、陳芮筠(Rui-Yun Chen)、林昭君(Chao-Chun Lin)、莊素蓉(Su-Jung Chuang),衛福部,110年全方位癌症防治策進計畫,$9754280,2021.1.1 ~ 2021.12.31
|
2﹒ |
個別型,無,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、楊啟瑞(Chi-Rei Yang)、楊美都(Mei-Due Yang)、謝明家、方信元(Hsin-Yuan Fang)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、洪耀欽(Yao-Ching Hung)、葉士芃(Shih-Peng Yeh)、劉良智(Liang-Chih Liu)、柯道維(Tao-Wei Ke)、林振源(Lin, Chen-Yuan)、陳自諒(Tzu-Liang Chen)、張兆祥(Chao-Hsiang Chang)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林文元(Wen-Yuan lin)、花俊宏(Chun-Hung Hua)、孟乃欣(Nai-Hsin Meng)、王約翰(John Wang)、徐華穗(Hua-Shai Hsu)、蔡伯邦(Po-Pang Tsai)、陳育傑(Yu-Chieh Chen)、王帝皓(Ti-Hao Wang)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh)、陳芮筠(Rui-Yun Chen)、林昭君(Chao-Chun Lin)、莊素蓉(Su-Jung Chuang),衛福部,109年全方位癌症防治策進計畫,$10358000,2020.1.1 ~ 2020.12.31
|
3﹒ |
個別型,無,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、楊啟瑞(Chi-Rei Yang)、楊美都(Mei-Due Yang)、方信元(Hsin-Yuan Fang)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、洪耀欽(Yao-Ching Hung)、葉士芃(Shih-Peng Yeh)、劉良智(Liang-Chih Liu)、柯道維(Tao-Wei Ke)、林振源(Lin, Chen-Yuan)、陳自諒(Tzu-Liang Chen)、張兆祥(Chao-Hsiang Chang)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林文元(Wen-Yuan lin)、花俊宏(Chun-Hung Hua)、孟乃欣(Nai-Hsin Meng)、王約翰(John Wang)、徐華穗(Hua-Shai Hsu)、蔡伯邦(Po-Pang Tsai)、陳育傑(Yu-Chieh Chen)、王帝皓(Ti-Hao Wang)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh)、陳芮筠(Rui-Yun Chen)、林昭君(Chao-Chun Lin)、張麗銀(Li-Yin Chang)、莊素蓉(Su-Jung Chuang),衛福部,108年全方位癌症防治策進計畫,$9500000,2019.1.1 ~ 2019.12.31
|
4﹒ |
個別型,A1051222-107,趙坤山(Kun-San Chao),邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(Tzu-Liang Chen)、柯道維(Tao-Wei Ke)、王輝明(Hwei-Ming Wang)、陳宏彰(Hung-Chang Chen)、黃郁純(Yu-Chuen Huang)、花俊宏(Chun-Hung Hua)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、吳錫金(Hsi-Chin Wu)、黃志平(Chi-Ping Huang)、蔡宗欣(Tzong-Shin Tzai)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、吳建廷(Chen-Teng Wu)、劉良智(Liang-Chih Liu)、吳曜充(Yao-Chung Wu)、陳芝蓉(Chih-Jung Chen)、鄭書(Yu-Shu Cheng)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、陳鴻仁(Hung-Jen Chen)、劉秋松(Chiu-Shong Liu)、陳毓隆(Yu-Lung Chen)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年) 107年後續擴充,$1803511,2018.10.5 ~ 2019.10.4
|
5﹒ |
個別型,DMR-108-164,鍾季容(Chi-Jung Chung),張兆祥(Chao-Hsiang Chang),附醫院內計畫,尿液揮發性有機物含量、LINE-1甲基化與泌尿上皮癌之相關性,$400000,2018.8.1 ~ 2019.6.30
|
6﹒ |
個別型,A1061223,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、楊美都(Mei-Due Yang)、陳自諒(Tzu-Liang Chen)、方信元(Hsin-Yuan Fang)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、洪耀欽(Yao-Ching Hung)、葉士芃(Shih-Peng Yeh)、劉良智(Liang-Chih Liu)、張兆祥(Chao-Hsiang Chang)、柯道維(Tao-Wei Ke)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林文元(Wen-Yuan lin)、王約翰(John Wang)、陳育傑(Yu-Chieh Chen)、張麗銀(Li-Yin Chang)、莊素蓉(Su-Jung Chuang)、孟乃欣(Nai-Hsin Meng)、花俊宏(Chun-Hung Hua)、楊啟瑞(Chi-Rei Yang)、徐華穗(Hua-Shai Hsu)、陳芮筠(Rui-Yun Chen)、蔡伯邦(Po-Pang Tsai)、林昭君(Chao-Chun Lin)、王帝皓(Ti-Hao Wang)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh),衛福部,107年癌症防治品質精進計畫,$11850000,2018.1.1 ~ 2018.12.31
|
7﹒ |
國家型,A1051222,趙坤山(Kun-San Chao),邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(William Tzu-Liang Chen)、柯道維(TAO-WEI KE)、花俊宏(Chun-Hung Hua)、張兆祥(Chang,Chao-Hsiang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、劉良智(Liu, Liang-Chih)、吳曜充(Yao-Chung Wu)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、黃郁純(YU-CHUEN HUANG)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年),$1241289,2017.2.16 ~ 2018.2.15
|
8﹒ |
個別型,BM10601010037,黃秋錦(Chiu-Ching Huang),(Hung-Chun Ch)、(Kuo-Hsiung Shu)、(Tzen-Wen Chen)、(Ming-Chang Wang)、(Bang-Gee Hsu)、(Chia-Chu Chang)、張兆祥(Chang,Chao-Hsiang)、(Hwai-I Yang)、陳朝榮(Chao-Jung Chen)、(Hsin-Chou Yang)、(Shu-Li Wang)、張志宗(Chiz-Tzung Chang)、周哲毅(Che-Yi Chou)、(Nian-Han Ma)、郭錦輯(Chin-Chi Kuo)、(Chien-Lung Chen),中研院,臺灣人體生物資料庫泌尿道上皮癌之生物標誌研發,$3500000,2017.1.1 ~ 2017.12.31
|
9﹒ |
國家型,A1051121,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、洪耀欽(Yao-Ching Hung)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、葉士芃(Su-Peng Yeh)、劉良智(Liu, Liang-Chih)、張兆祥(Chang,Chao-Hsiang)、柯道維(TAO-WEI KE)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林文元(Wen-Yuan Lin)、王約翰(John Wang)、謝右文(Yow-Wen Hsieh)、蔡麗雲(Li-Yun Tsai)、謝淑惠(Shwn-Huey Shieh)、廖惠娟(Hui-Chuan Liao)、孟乃欣(Nai-Hsin Meng)、花俊宏(Chun-Hung Hua)、楊啟瑞(Che-Rei Yang)、徐華穗(Hua-Shai Hsu)、詹佳穎(Chia-Ing Jan)、蔡伯邦(Po-Pang Tsai)、林昭君(Chao-Chun Lin)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh)、簡君儒(Chun-Ru Chien)、楊世能(Shih-Neng Yang)、白禮源(Li-Yuan Bai),衛福部,106醫院癌症診療品質精進計畫,$11540000,2017.1.1 ~ 2017.12.31
|
10﹒ |
臨床試驗與研究計畫,CMUH105-REC3-096,吳錫金(Wu, Hsi-Chin),楊啟瑞(Yang, Che-Rei)、張兆祥(Chang, Chao-Hsiang)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin),附醫廠商計畫,ODM-201相較於安慰劑、加上標準雄性素去除療法與docetaxel使用於轉移性荷爾蒙敏感性攝護腺癌病患的一項隨機分配、雙盲、安慰劑對照第三期研究,$12175709,2017.1.1 ~ 2017.12.31
|
11﹒ |
臨床試驗與研究計畫,CMUH105-REC2-108,張兆祥(Chang, Chao-Hsiang),吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、葉進仲(Yeh, Chin-Chung)、謝博帆(Po-Fan Hsieh)、連啟舜(Chi-Shun Lien)、陳冠亨(Guang-Heng Chen)、陳汶吉(Chen, Wen-Chi)、黃志平(Huang, Chi-Ping),附醫廠商計畫,一項研究亞洲攝護腺癌病患使用 ELIGARD®的安全性、療效和生活品質之第四期、介入性試驗(ELIGANT),$1110586,2017.1.1 ~ 2017.12.31
|
12﹒ |
臨床試驗與研究計畫,CMUH106-REC3-010,張兆祥(Chang, Chao-Hsiang),吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、林精湛(Ching-Chan Lin)、葉士芃(Yeh, Su-Peng),附醫廠商計畫,一項第III期、多中心、隨機分配、安慰劑對照、雙盲試驗,以ATEZOLIZUMAB (抗PD-L1抗體)作為輔助治療用於腎切除術後發生轉移風險偏高之腎細胞癌病患,$3864947,2017.1.1 ~ 2017.12.31
|
13﹒ |
臨床試驗與研究計畫,CMUH106-REC2-087,吳錫金(Wu, Hsi-Chin),張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、張議徽(Yi-Huei Chang)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項第二期試驗,針對患有轉移性去勢療法無效之攝護腺癌,同時帶有DNA修復基因異常的男性患者,評估Niraparib的療效和安全性,$1698023,2017.1.1 ~ 2017.12.31
|
14﹒ |
臨床試驗與研究計畫,CMUH106-REC3-081,吳錫金(Wu, Hsi-Chin),張兆祥(Chang, Chao-Hsiang)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、林哲弘(Che-Hung Lin)、葉士芃(Yeh, Su-Peng),附醫廠商計畫,一項第III期、隨機分配、雙盲、安慰劑對照的多中心試驗,針對無症狀或有輕度症狀且先前未曾接受治療的轉移性去勢抗性前列腺癌成人男性患者,給予IPATASERTIB併用ABIRATERONE和PREDNISONE/PREDNISOLONE或安慰劑併用ABIRATERONE和PREDNISONE/PREDNISOLONE進行比較,$2965257,2017.1.1 ~ 2017.12.31
|
15﹒ |
臨床試驗與研究計畫,CMUH106-REC2-071,張兆祥(Chang, Chao-Hsiang),吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh)、林哲弘(Che-Hung Lin)、張議徽(Yi-Huei Chang)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項第三期、隨機分配、雙盲、安慰劑對照臨床試驗,以Pembrolizumab (MK-3475) 單一療法做為腎細胞癌腎切除術後的輔助性治療(KEYNOTE-564),$3565937,2017.1.1 ~ 2017.12.31
|
16﹒ |
臨床試驗與研究計畫,CMUH106-REC2-099,張兆祥(Chang, Chao-Hsiang),葉士芃(Yeh, Su-Peng)、吳錫金(Wu, Hsi-Chin)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、林哲弘(Che-Hung Lin)、林精湛(Ching-Chan Lin)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項隨機分配、雙盲、第2期試驗,評估腎細胞癌在接受一種血管內皮生長因子(VEGF)標靶治療後,使用二種不同起始劑量Lenvatinib (18mg相較於14mg QD)合併Everolimus (5mg QD)之安全性和療效,$4831661,2017.1.1 ~ 2017.12.31
|
17﹒ |
臨床試驗與研究計畫,CMUH106-REC2-121,張兆祥(Chang, Chao-Hsiang),吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,PARACHUTE:Pazopanib治療各種狀況晚期腎細胞癌患者之臨床療效及安全性實務評估;一項前瞻性、非介入性、觀察性研究,$233967,2017.1.1 ~ 2017.12.31
|
18﹒ |
臨床試驗與研究計畫,CMUH106-REC1-131,葉士芃(Yeh, Su-Peng),林哲弘(Che-Hung Lin)、林維卿(Lin, Wei-Ching)、楊啟瑞(Yang, Che-Rei)、張兆祥(Chang, Chao-Hsiang),附醫廠商計畫,一項針對不適用Cisplatin之泌尿上皮癌患者,使用Pembrolizumab (MK-3475)併用Epacadostat (INCB024360)或安慰劑之第三期、隨機分配、雙盲臨床試驗(KEYNOTE-672/ECHO-307),$1962792,2017.1.1 ~ 2017.12.31
|
19﹒ |
臨床試驗與研究計畫,CMUH105-REC3-093,張兆祥(Chang, Chao-Hsiang),吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh),附醫廠商計畫,一項第三期、隨機分配、開放性試驗,評估Pembrolizumab(MK-3475)併用Axitinib相較於Sunitinib單一療法做為局部晚期或轉移性腎細胞癌第一線療法的療效和安全性(KEYNOTE-426),$2941481,2017.1.1 ~ 2017.12.31
|
20﹒ |
臨床試驗與研究計畫,DMR101-IRB1-062,張兆祥(Chang, Chao-Hsiang),附醫廠商計畫,腎臟癌之Axitinib輔助治療:一項隨機分配、雙盲、第三期試驗,比較腎細胞癌高復發風險受試者使用Axitinib或安慰劑的輔助治療,$4603905,2017.1.1 ~ 2017.12.31
|
21﹒ |
臨床試驗與研究計畫,CMUH103-REC1-038,吳錫金(Wu, Hsi-Chin),張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、陳國樑(Chen, Kuo-Liang)、鄒頷龍、黃志平(Huang, Chi-Ping),附醫廠商計畫,第二期雙盲隨機分組安慰劑控制臨床試驗研究MCS®於預防男性前列腺癌之效果及安全性,$5762291,2017.1.1 ~ 2017.12.31
|
22﹒ |
臨床試驗與研究計畫,CMUH105-REC2-074,葉士芃(Yeh, Su-Peng),楊啟瑞(Yang, Che-Rei)、張兆祥(Chang, Chao-Hsiang)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項第III期、多中心、隨機分配、安慰劑對照、雙盲試驗,比較ATEZOLIZUMAB (抗PD-L1抗體)併用GEMCITABINE / CARBOPLATIN與GEMCITABINE / CARBOPLATIN單獨治療用於未曾接受治療且不符合CISPLATIN療法資格的局部晚期或轉移性泌尿道上皮癌之病患,$3587311,2017.1.1 ~ 2017.12.31
|
23﹒ |
臨床試驗與研究計畫,CMUH103-REC1-126,葉士芃(Yeh, Su-Peng),林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、張兆祥(Chang, Chao-Hsiang)、吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei),附醫廠商計畫,一項第三期、開放標示、多中心、隨機分配之臨床試驗,比較MPDL3280A(抗PD-L1抗體)與化學治療,用於含鉑藥物化學治療無效的局部晚期或轉移性尿路上皮膀胱癌患者之療效及安全性評估,$2009873,2017.1.1 ~ 2017.12.31
|
24﹒ |
臨床試驗與研究計畫,CMUH104-REC2-150,吳錫金(Wu, Hsi-Chin),張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、連啟舜(Chi-Shun Lien)、黃志平(Huang, Chi-Ping),附醫廠商計畫,一項第三期隨機研究,針對接受確定性療法後其高風險非轉移性前列腺癌仍惡化的男性患者,探討 Enzalutamide + Leuprolide 療法、Enzalutamide 單一療法及安慰劑 + Leuprolide 療法的療效和安全性,$4329073,2017.1.1 ~ 2017.12.31
|
25﹒ |
臨床試驗與研究計畫,CMUH103-REC2-029,吳錫金(Wu, Hsi-Chin),張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、葉進仲(Yeh, Chin-Chung)、黃志平(Huang, Chi-Ping)、陳國樑(Chen, Kuo-Liang)、陳汶吉(Chen, Wen-Chi),附醫廠商計畫,一項亞洲、多國、第三期、隨機、雙盲、安慰劑對照、針對未曾接受化學治療且使用雄性素去除療法後失敗之漸進性轉移性攝護腺癌患者使用口服enzalutamide之療效與安全性的試驗,$4439602,2017.1.1 ~ 2017.12.31
|
26﹒ |
個別型,DMR-106-065,連啟舜(Chi-Shun Lien),張兆祥(Chang,Chao-Hsiang)、鍾季容(Chi-Jung Chung),附醫院內計畫,葉酸及其相關之臨床藥物、LINE-1甲基化和泌尿上皮癌預後之相關,$372900,2016.8.1 ~ 2017.7.31
|
27﹒ |
個別型,BM10501010042,黃秋錦(Chiu-Ching Huang),陳、徐國雄、陳振文、王明誠、張家築、徐邦治、楊懷一、張兆祥(Chang,Chao-Hsiang)、(Hsin-Chou Yang)、(Shu-Li Wang)、陳朝榮(Chao-Jung Chen)、張志宗(Chiz-Tzung Chang)、周哲毅(Che-Yi Chou)、郭錦輯(Chin-Chi Kuo)、(Nian-Han Ma)、陳建隆、盧智強(Lu, Chih-Chiang)、楊淵隆、謝登富、吳勝堂,中研院,臺灣人體生物資料庫泌尿道上皮癌之生物標誌研發,$6000000,2016.1.1 ~ 2016.12.31
|
28﹒ |
臨床試驗與研究計畫,DMR98-IRB-184,張兆祥(Chang,Chao-Hsiang),附醫廠商計畫,YM178第三期試驗-針對有膀胱過動症症狀之患者進行隨機、雙盲、平行分組、安慰劑及有效對照組之多中心試驗,$1783460,2016.1.1 ~ 2016.12.31
|
29﹒ |
臨床試驗與研究計畫,DMR101-IRB1-062,張兆祥(Chang,Chao-Hsiang),附醫廠商計畫,腎臟癌之Axitinib輔助治療:一項隨機分配、雙盲、第三期試驗,比較腎細胞癌高復發風險受試者使用Axitinib或安慰劑的輔助治療,$3958818,2016.1.1 ~ 2016.12.31
|
30﹒ |
臨床試驗與研究計畫,DMR101-IRB1-112,張兆祥(Chang,Chao-Hsiang),附醫廠商計畫,ㄧ項開放標示、單一組別、多中心第二期臨床試驗,評估TLC388用於治療晚期/轉移性腎細胞癌患者的療效與安全性,$551483,2016.1.1 ~ 2016.12.31
|
31﹒ |
臨床試驗與研究計畫,CMUH102-REC1-106,張兆祥(Chang,Chao-Hsiang),附醫廠商計畫,一項針對已接受 4 週 Solifenacin 及准許額外舒緩藥物以治療膀胱過動症 (OAB) 症狀的尿失禁 OAB 受試者,評估 Solifenacin 外加 Mirabegron 之療效與安全性的隨機分配、雙盲、多中心研究,$241127,2016.1.1 ~ 2016.12.31
|
32﹒ |
臨床試驗與研究計畫,CMUH103-REC2-031,吳錫金(Wu,Hsi-Chin),張兆祥(Chang,Chao-Hsiang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang),附醫廠商計畫,一項前瞻性、縱貫、多國參與、觀察性研究,描述在接受確定性攝護腺癌治療後經過生化檢測證明出現復發並具有臨床結果差的高風險的男性病人、患有抗去勢型攝護腺癌的男性病人,以及首次診斷即確定為轉移性攝護腺癌的男性病人的照護模式和結果,$60261,2016.1.1 ~ 2016.12.31
|
33﹒ |
臨床試驗與研究計畫,CMUH103-REC2-029,吳錫金(Wu,Hsi-Chin),張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)、陳國樑(Chen, Kuo-Liang)、陳汶吉(Chen, Wen-Chi),附醫廠商計畫,一項亞洲、多國、第三期、隨機、雙盲、安慰劑對照、針對未曾接受化學治療且使用雄性素去除療法後失敗之漸進性轉移性攝護腺癌患者使用口服enzalutamide之療效與安全性的試驗,$4464250,2016.1.1 ~ 2016.12.31
|
34﹒ |
臨床試驗與研究計畫,CMUH103-REC1-038,吳錫金(Wu,Hsi-Chin),張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、陳國樑(Chen, Kuo-Liang)、鄒頷龍、黃志平(Chi-Ping Huang),附醫廠商計畫,第二期雙盲隨機分組安慰劑控制臨床試驗研究MCS®於預防男性前列腺癌之效果及安全性,$900000,2016.1.1 ~ 2016.12.31
|
35﹒ |
臨床試驗與研究計畫,CMUH103-REC2-105,楊啟瑞(Che-Rei Yang),張兆祥(Chang,Chao-Hsiang)、葉進仲(Yeh, Chin-Chung)、吳錫金(Wu,Hsi-Chin)、黃志平(Chi-Ping Huang)、陳汶吉(Chen, Wen-Chi),附醫廠商計畫,一項開放性、單組試驗,以評估晚期前列腺癌受試者使用Leuprolide Mesylate注射液(LMIS 50mg)的安全性、療效與藥物動力學型態,$649755,2016.1.1 ~ 2016.12.31
|
36﹒ |
臨床試驗與研究計畫,CMUH103-REC1-135,吳錫金(Wu,Hsi-Chin),張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)、葉士芃(Su-Peng Yeh)、林精湛(Ching-Chan Lin),附醫廠商計畫,一項第三期隨機臨床試驗,於患有已復發或已惡化轉移性尿路上皮癌的受試者中比較pembrolizumab(MK-3475)與paclitaxel、docetaxel或vinflunine,$1119213,2016.1.1 ~ 2016.12.31
|
37﹒ |
臨床試驗與研究計畫,CMUH103-REC1-126,葉士芃(Su-Peng Yeh),林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang),附醫廠商計畫,一項第三期、開放標示、多中心、隨機分配之臨床試驗,比較MPDL3280A(抗PD-L1抗體)與化學治療,用於含鉑藥物化學治療無效的局部晚期或轉移性尿路上皮膀胱癌患者之療效及安全性評估,$2937875,2016.1.1 ~ 2016.12.31
|
38﹒ |
臨床試驗與研究計畫,CMUH104-REC2-030,吳錫金(Wu,Hsi-Chin),張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)、 葉士芃、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項使用Pembrolizumab (MK-3475)於晚期無法以手術切除或轉移性尿路上皮癌患者的第二期臨床試驗,$663450,2016.1.1 ~ 2016.12.31
|
39﹒ |
臨床試驗與研究計畫,CMUH104-REC2-135,張兆祥(Chang,Chao-Hsiang),楊啟瑞(Che-Rei Yang)、吳錫金(Wu,Hsi-Chin)、葉士芃(Su-Peng Yeh),附醫廠商計畫,上市後觀察性登記探討INLYTA®用於治療台灣晚期腎細胞癌患者的使用劑量、安全性及效益,$28533,2016.1.1 ~ 2016.12.31
|
40﹒ |
臨床試驗與研究計畫,CMUH104-REC2-150,吳錫金(Wu,Hsi-Chin),張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、連啟舜(Chi-Shun Lien)、黃志平(Chi-Ping Huang),附醫廠商計畫,一項第三期隨機研究,針對接受確定性療法後其高風險非轉移性前列腺癌仍惡化的男性患者,探討 Enzalutamide + Leuprolide 療法、Enzalutamide 單一療法及安慰劑 + Leuprolide 療法的療效和安全性,$154661,2016.1.1 ~ 2016.12.31
|
41﹒ |
臨床試驗與研究計畫,CMUH105-REC2-074,葉士芃(Su-Peng Yeh),楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項第III期、多中心、隨機分配、安慰劑對照、雙盲試驗,比較ATEZOLIZUMAB (抗PD-L1抗體)併用GEMCITABINE / CARBOPLATIN與GEMCITABINE / CARBOPLATIN單獨治療用於未曾接受治療且不符合CISPLATIN療法資格的局部晚期或轉移性泌尿道上皮癌之病患,$188445,2016.1.1 ~ 2016.12.31
|
42﹒ |
臨床試驗與研究計畫,CMUH105-REC2-091,張兆祥(Chang,Chao-Hsiang),葉士芃(Su-Peng Yeh)、林精湛(Ching-Chan Lin)、楊啟瑞(Che-Rei Yang)、吳錫金(Wu,Hsi-Chin)、陳冠亨(Guang-Heng Chen)、黃志平(Chi-Ping Huang),附醫廠商計畫,針對罹患局部晚期或轉移之泌尿上皮癌,完成第一線含鉑化學治療後無疾病惡化之患者,比較接受維持性治療Avelumab* (MSB0010718C)合併最佳支持性照護或單獨最佳支持性照護的一項第三期、多中心、多國、隨機分配、開放性、平行組別試驗,$694252,2016.1.1 ~ 2016.12.31
|
43﹒ |
臨床試驗與研究計畫,CMUH105-REC3-093,張兆祥(Chang,Chao-Hsiang),吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)、葉士芃(Su-Peng Yeh)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh),附醫廠商計畫,一項第三期、隨機分配、開放性試驗,評估Pembrolizumab(MK-3475)併用Axitinib相較於Sunitinib單一療法做為局部晚期或轉移性腎細胞癌第一線療法的療效和安全性(KEYNOTE-426),$533465,2016.1.1 ~ 2016.12.31
|
44﹒ |
個別型,DMR-105-049,張兆祥(Chang,Chao-Hsiang),鍾季容(Chi-Jung Chung),附醫院內計畫,中草藥、氧化壓力與上泌尿道癌症之相關性研究,$200000,2015.8.1 ~ 2016.7.31
|
45﹒ |
整合型(召集人、總主持人),CMU102-BC-12,鍾季容(Chi-Jung Chung),張兆祥(Chang,Chao-Hsiang),本校(含附醫),農藥、氧化壓力與泌尿系統癌症之相關性,$600000,2014.5.1 ~ 2015.5.30
|
46﹒ |
個別型,BM103010089,黃秋錦(Chiu-Ching Huang),陳鴻鈞(Hung-Chun Chen)、徐國雄(Kuo-Hsiung Shu)、陳振文(Tzen-Wen Chen)、王明誠(Ming-Chang Wang)、方德昭(Te-Chao Fang)、張家築(Chia-Chu Chang)、張兆祥(Chang,Chao-Hsiang)、楊哲彥(Tse-Yen Yang)、陳朝榮(Chao-Jung Chen)、楊欣洲(Hsin-Chou Yang),中研院,臺灣人體生物資料庫泌尿道上皮癌之生物標誌研發,$7500000,2014.1.1 ~ 2014.12.31
|
47﹒ |
個別型,NSC101-2314-B-039-025-MY3,鍾季容(Chi-Jung Chung),張兆祥(Chang,Chao-Hsiang),國科會,DNA甲基化、重金屬暴露與甲基化轉移酵素基因多形性和泌尿系統癌症之相關性研究(2/3),$1380000,2013.8.1 ~ 2014.7.31
|
48﹒ |
個別型,BM102021124,黃秋錦(Chiu-Ching Huang),陳鴻鈞(Hung-Chun Chen)、徐國雄(Kuo-Hsiung Shu)、陳振文(Tzen-Wen Chen)、王明誠(Ming-Chang Wang)、方德昭(Te-Chao Fang)、張家築(Chia-Chu Chang)、張兆祥(Chang,Chao-Hsiang)、楊懷壹(Hwai-I Yang)、陳朝榮(Chao-Jung Chen)、(Hsin-Chou Yang)、蔡文正(Tsai, Wen-Chen)、鍾季容(Chi-Jung Chung)、張志宗(Chiz-Tzung Chang)、(Wei-Yu Lin)、周哲毅(Che-Yi Chou)、鄭光甫(Kuang-Fu Cheng),中研院,臺灣人體生物資料庫泌尿道上皮癌之生物標誌研發,$5000000,2013.3.26 ~ 2013.12.31
|
49﹒ |
個別型,CMU101-N1-02,鍾季容(Chi-Jung Chung),張兆祥(Chang,Chao-Hsiang)、劉紹興(Saou-Hsing Liou),本校(含附醫),DNA甲基化與重金屬暴露和泌尿系統癌症之相關性研究,$350000,2012.9.20 ~ 2013.7.31
|
50﹒ |
個別型,NSC101-2314-B-039-025-MY3,鍾季容(Chi-Jung Chung),張兆祥(Chang,Chao-Hsiang),國科會,DNA甲基化、重金屬暴露與甲基化轉移酵素基因多形性和泌尿系統癌症之相關性研究,$1380000,2012.8.1 ~ 2013.7.31
|
51﹒ |
國家型,101CANCER,周德陽(Der-Yang Cho),方信元(Hsin-Yuan Fang)、白禮源(Li-Yuan Bai)、何永仁(Yung-Jen Ho)、李郁芬(Yu-Fen Li)、林文元(Wen-Yuan Lin)、花俊宏(Chun-Hung Hua)、邱昌芳(Chang-Fang Chiu)、柯道維(TAO-WEI KE)、洪耀欽(Yao-Ching Hung)、孫茂峰(SUN, MAO-FENG)、張兆祥(Chang,Chao-Hsiang)、梁基安(Ji-An Liang)、許玲女(Ling-Nu Hsu)、陳自諒(William Tzu-Liang Chen)、陳志毅(Chih-Yi Chen)、陳碧惠(Pi-Hui Chen)、彭成元(Cheng-Yuan Peng)、楊美都(Mei-Due Yang)、葉士芃(Su-Peng Yeh)、葉聯舜(Lian-Shung Yeh)、劉良智(Liu, Liang-Chih)、劉秋松(Chiu-Shong Liu)、蔡伯邦(Po-Pang Tsai)、蔡銘修(Ming-Hsui Tsai)、謝右文(Yow-Wen Hsieh)、謝淑惠(Shwn-Huey Shieh)、林智一(Tze-Yi Lin)、謝清昀(Ching-Yun Hsieh),衛福部,101年醫院癌症醫療品質提升計畫,$14285090,2012.1.1 ~ 2012.12.31
|
52﹒ |
個別型,NSC 100-2314-B-039-035-,鍾季容(Chi-Jung Chung),(Hsueh,Yu-Mei)、張兆祥(Chang,Chao-Hsiang)、褚志斌(Chuu,Chih-Pin),國科會,單碳代謝循環因子、DNA甲基化、尿液砷代謝型態及甲基化相關酵素GNMT基因多形性與泌尿上皮癌之研究,$1200000,2011.8.1 ~ 2012.7.31
|
53﹒ |
個別型,DMR-101-053,陳至正(Chen, Chi-Cheng),石志榮(Chih-Rong, Shyr)、張兆祥(Chang,Chao-Hsiang),附醫院內計畫,上泌尿道泌尿上皮癌患者的性別差異 - 雄性荷爾蒙接受體在癌化過程的角色,$191000,2011.8.1 ~ 2012.7.31
|
54﹒ |
個別型,DMR-101-054,黃志平(Chi-Ping Huang),禇志斌(Chih-Pin Chuu)、鍾季容(Chi-Jung Chung)、張兆祥(Chang,Chao-Hsiang),附醫院內計畫,系統性研究攝護腺癌惡化中之生物標誌,$150000,2011.8.1 ~ 2012.7.31
|
55﹒ |
個別型,DMR-100-163,鍾季容(Chi-Jung Chung),張兆祥(Chang,Chao-Hsiang),附醫院內計畫,DNA甲基化及尿液砷代謝型態與泌尿上皮癌之相關性研究,$300000,2011.2.1 ~ 2011.12.31
|
56﹒ |
國家型,1000104CANCER,周德陽(Der-Yang Cho),陳志毅(Chih-Yi Chen)、邱昌芳(Chang-Fang Chiu)、孫茂峰(SUN, MAO-FENG)、蔡銘修(Ming-Hsui Tsai)、陳自諒(William Tzu-Liang Chen)、梁基安(Ji-An Liang)、韓鴻志(Horng-Jyh Harn)、楊美都(Mei-Due Yang)、方信元(Hsin-Yuan Fang)、葉士芃(Su-Peng Yeh)、劉秋松(Chiu-Shong Liu)、張兆祥(Chang,Chao-Hsiang)、謝右文(Yow-Wen Hsieh)、羅偉忠(Lo Woei Chung)、林文元(Wen-Yuan Lin)、何永仁(Yung-Jen Ho)、彭成元(Cheng-Yuan Peng)、洪耀欽(Yao-Ching Hung)、葉聯舜(Lian-Shung Yeh)、劉良智(Liu, Liang-Chih)、蔡伯邦(Po-Pang Tsai)、花俊宏(Chun-Hung Hua)、柯道維(TAO-WEI KE)、白禮源(Li-Yuan Bai)、謝清昀(Ching-Yun Hsieh)、許玲女(Ling-Nu Hsu)、謝淑惠(Shwn-Huey Shieh)、陳碧惠(Pi-Hui Chen)、李郁芬(Yu-Fen Li)、何文照(Wen-Chao Ho),衛福部,100年至101年醫院癌症醫療品質提昇計劃(100年度),$13640000,2011.1.4 ~ 2011.12.31
|
57﹒ |
國家型,無,周德陽(Der-Yang Cho),陳志毅(Chih-Yi Chen)、林璨(Tsann Lin)、孫茂峰(SUN, MAO-FENG)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(William Tzu-Liang Chen)、梁基安(Ji-An Liang)、韓鴻志(Horng-Jyh Harn)、楊美都(Mei-Due Yang)、劉秋松(Chiu-Shong Liu)、張兆祥(Chang,Chao-Hsiang)、謝右文(Yow-Wen Hsieh)、廖裕民(Yu-Min Liao)、林文元(Wen-Yuan Lin)、何永仁(Yung-Jen Ho)、彭成元(Cheng-Yuan Peng)、洪耀欽(Yao-Ching Hung)、葉聯舜(Lian-Shung Yeh)、陳芝蓉(Chih-Jung Chen)、蔡伯邦(Po-Pang Tsai)、花俊宏(Chun-Hung Hua)、柯道維(KE TAO-WEI)、丁文謙(Wen-Chien Ting)、謝清昀(Ching-Yun Hsieh)、許玲女(Ling-Nu Hsu)、謝淑惠(Shwn-Huey Shieh)、陳碧惠(Pi-Hui Chen)、龍紀萱(Chi-Hsuan Lung)、李郁芬(Yu-Fen Li)、何文照(Wen-Chao Ho),,行政院衛生署國民健康局99年醫院癌症醫療品質提升補助計劃,$12600000,2010.1.14 ~ 2010.12.31
|
58﹒ |
個別型,DMR-99-065,林維卿(Wei-Ching Lin),張兆祥(Chang,Chao-Hsiang)、蔡政安(Tsai, Chen-An),,評估利用水分子擴散磁振影像﹑顯影劑後動態磁振影像合併T2影像做膀胱癌的診斷及分期之臨床價值,$300000,2009.8.1 ~ 2010.7.31
|
59﹒ |
個別型,DNR-99-159,黃志平(Chi-Ping Huang),張兆祥(Chang,Chao-Hsiang),附醫院內計畫,急性尿滯留對於男性病患血清中的攝護腺特異抗原數值之影響,$150000,2008.8.1 ~ 2009.6.30
|
60﹒ |
個別型,DMR-97-065,鄒頡龍(Chieh-Lung Chou),張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin),附醫院內計畫,年輕女性不同排尿姿勢對尿流速與餘尿的影響,$250000,2007.8.1 ~ 2008.7.31
|
61﹒ |
個別型,CMU95-207,陳淑月,林綽娟(Lin,Chouh-Jiuan)、吳錫金(Wu,His-Chin)、張兆祥(Chang,Chao-Hsian)、鄒頡龍,本校(含附醫),婦女非坐式使用公廁坐式馬桶與其排尿之關係研究,$500000,2006.8.1 ~ 2007.7.31
|
62﹒ |
個別型,DOH-BHP-95-01,林正介(Lin,Cheng-Chieh),彭慶添(Peng,Ching-Tien)、鄭隆賓(Jeng,Long-Bin)、吳錫金(Wu,His-Chin)、邱昌芳(Chiu,Chang-Fang)、許南榮(Hsu,Nan-Yung)、蔡銘修(Tsai,Ming-Hsui)、張兆祥(Chang,Chao-Hsian)、周德陽(Cho,Der-Yang)、夏德椿(Hsia,Te-Chun)、洪耀欽,衛福部,95-96年度安寧共同照護計畫,$2100000,2006.1.1 ~ 2007.12.31
|
63﹒ |
個別型,DMR-95-054,吳錫金(Hsi-Chin Wu),張兆祥(Chao-Hsiang Chang),本校(含附醫),局限性攝護腺癌治療的生活品質評估:以歐洲癌症治療與研究組織生活品質核心問卷及攝護腺癌生活品質問卷評估,$100000,2005.7.1 ~ 2006.6.30
|
64﹒ |
個別型,DMR-95-055,鄒頡龍(Chieh-Lung Chou),孟乃欣(Nai-Hsin Meng)、楊佩瑜(Pei-Yu Yang)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin),附醫院內計畫,智能障礙孩童的排尿障礙,$100000,2005.7.1 ~ 2006.6.30
|
65﹒ |
個別型,DOH-BHP-94-03,林正介(Lin,Cheng-Chieh),彭慶添(Peng,Ching-Tien)、鄭隆賓(Jeng,Long-Bin)、陳志毅、吳錫金(Wu,His-Chin)、邱昌芳(Chiu,Chang-Fang)、許南榮(Hsu,Nan-Yung)、蔡銘修(Tsai,Ming-Hsui)、張兆祥(Chang,Chao-Hsian)、周德陽(Cho,Der-Yang)、夏德椿(Hsia,Te-Chun),衛福部,九十四年度安寧共同照護計畫,$1100000,2005.1.1 ~ 2005.12.31
|
|
獲獎/Award (獲獎名稱,給獎單位,獲獎日期)
|
1﹒ |
Second Prize in the CURy Best Abstract Award,The 3rd World Congress on Controversies in Urology (CURy),2010.02.27
|
|